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ABSTRACT

KEYWORDS

Over the last 30 to 40 years, improvements in technology, as well as changing clinical practice regarding the
appropriateness of long-term ventilation in patients with “non-curable” disorders, have resulted in increasing
numbers of children surviving what were previously considered fatal conditions. This has come but at the
expense of requiring ongoing, long-term prolonged mechanical ventilation (both invasive and noninvasive).
Although there are many publications pertaining to speciﬁc aspects of home mechanical ventilation (HMV) in
children, there are few comprehensive guidelines that bring together all of the current literature. In 2011 the
Canadian Thoracic Society HMV Guideline Committee published a review of the available English literature on
topics related to HMV in adults, and completed a detailed guideline that will help standardize and improve the
assessment and management of individuals requiring noninvasive or invasive HMV. This current document is
intended to be a companion to the 2011 guidelines, concentrating on the issues that are either unique to
children on HMV (individuals under 18 years of age), or where common pediatric practice diverges signiﬁcantly
from that employed in adults on long-term home ventilation. As with the adult guidelines,1 this document
provides a disease-speciﬁc review of illnesses associated with the necessity for long-term ventilation in children,
including children with chronic lung disease, spinal muscle atrophy, muscular dystrophies, kyphoscoliosis,
obesity hypoventilation syndrome, and central hypoventilation syndromes. It also covers important common
themes such as airway clearance, the ethics of initiation of long-term ventilation in individuals unable to give
consent, the process of transition to home and to adult centers, and the impact, both ﬁnancial, as well as social,
that this may have on the child’s families and caregivers. The guidelines have been extensively reviewed by
international experts, allied health professionals and target audiences. They will be updated on a regular basis
to incorporate any new information.

Airway clearance strategies;
central hypoventilation
syndrome; chronic
obstructive pulmonary
diseases; Duchenne muscular
dystrophy; ethics; home
mechanical ventilation;
kyphoscoliosis; muscular
dystrophies; myopathies;
myotonic dystrophy; obesity
hypoventilation syndrome;
prolonged mechanical
ventilation; spinal muscle
atrophy; transition
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Section 1: Introduction
Similar to that in adult medicine, improvements in available
technology and clinical care have resulted in increasing
CONTACT Canadian Thoracic Society
*Shared ﬁrst authorship
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numbers of children being placed on long-term home mechanical ventilation (HMV). There has been a growing realization
that long-term institutional care is not the optimal environment for these children’s emotional and intellectual growth.
Along with the rising costs of hospital care, and the family’s
appropriate desire to care for these children within their own
family environment, there has been greater demand for HMV
in children. The present HMV clinical practice guideline is
intended to be a resource for physicians, health care providers,
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policy makers and families of individuals at risk for or currently
using ventilatory support in the home. The objective is to identify and support ventilated children who are presently at home,
as well as those transitioning to home-based care where the
quality of life (QoL) is greatest and costs are minimized. Developed by the Canadian Thoracic Society (CTS), these guidelines
intend to provide the most up-to-date information and evidence-based recommendations to enable practitioners to manage the provision of preventive airway management and HMV.
These guidelines are composed of disease-speciﬁc sections in addition to overriding subjects such as ethical considerations, transition to home, transition to adult care, and
airway clearance. Within this sphere of practice, even within
adult medicine, there are extremely few prospective or randomized trials, and even fewer in children.
Again, as with the adult guidelines, the recommendations provided strive to achieve a balance between an
exceptional standard of care illustrated in the literature
and the reality of health care in Canada, where geographical and economic barriers may require adaptation, to
ensure feasible yet safe care. This approach may also allow
greater applicability to jurisdictions where, for example,
polysomnography (PSG) may be unavailable or so difﬁcult
to obtain due to present barriers to appropriate, timely
introduction and/or follow-up of noninvasive ventilation
(NIV). As with the adult guidelines, some subjects considered to be important by the committee are not addressed
in the literature. On important issues for which literature
is lacking, but strong expert opinion was available, recommendations were made by the HMV Guideline Committee.
Preventive airway management and HMV in children is
a complex, interdisciplinary component of respiratory care
and expert clinical practice. There is a continuum of
chronic disease management involving many layers of
expertise from government and professional education to
home care services, acute and chronic health facilities and
independent living facilities.
The present document represents the executive summary of the guideline. The source document, which is
more detailed and includes research questions identiﬁed by
the committee, and evidence tables, is available online at
www.respiratoryguidelines.ca/guideline/home-ventilationchildren.
Question
What evidence is available to inform the practice of HMV in
children and lead to better individual, caregiver, and system
outcomes?
Objective
The objective of the present clinical practice guideline is to
provide guidance on the role of mechanical ventilation for
children in the home setting. A guideline on this topic is
needed to inform best practices, provide a basis to identify
gaps in care and provide direction for future research. Speciﬁcally this guideline focuses on invasive ventilation and
positive pressure noninvasive ventilation (NIV). Continuous

positive pressure
tionally, negative
lators have been
they have been
ventilators.

ventilation (CPAP) is not discussed Addipressure and positive pressure body ventiexcluded from these guidelines given that
replaced with portable positive pressure

Target population
The current clinical practice guideline applies to all children
who are at risk for or are using HMV. Individuals with spinal
muscular atrophy (SMA), central hypoventilation syndrome,
speciﬁcally congenital (CCHS), chronic lung disease of infancy
(CLDI), kyphoscoliosis, obesity hypoventilation syndrome
(OHS), Duchenne muscular dystrophy (DMD), and muscular
dystrophies (MDs) other than DMD, are of special interest and
are considered individually in the present clinical practice
guideline.

Target users
The present clinical practice guideline is intended for use by
the health care teams that care for individuals who are at
risk for or require ventilatory assistance. Respirologists,
physiatrists, neurologists, family practitioners and community pediatricians, nurses, respiratory therapists, physiotherapists, and other health care professionals can use these
guidelines to help inform their clinical practice with regard
to HMV.

Methodology
Guideline development
This clinical practice guideline was developed according to
the convention of the 23-item AGREE II instrument – the
current gold standard in the appraisal of practice guidelines.1 The HMV Expert Committee was interprofessional
comprised of HMV clinicians with content expertise in
each of the topic areas. An initial systematic review of the
literature was completed current to June 2010. A second
review of the literature was also performed through to
August 2015. In accordance with the CTS guideline review
process, before completion, CTS staff distributed the guideline for formal review by: 1) 3 international content experts,
and 2) 2 national reviewers that rated the guideline using
the AGREE II instrument. These reviews and AGREE II
checklists were provided to the CTS guidelines committee.
We then provided responses to the comments and made
corresponding changes to the document. The authors were
blinded to the identities of the reviewers. All reviews and
author responses are posted, along with author conﬂicts of
interest, at respiratoryguidelines.ca.
Final consensus on the recommendations from the CTS
HMV Committee was reached through a formal voting process
that was anonymized. In accordance with the Canadian Thoracic Society’s Guideline update process, these guidelines will
be reviewed every 3 years or sooner.
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Table 1. Grading recommendations.
Grade of recommendation/
description

Beneﬁt versus risk and burdens

Methodological quality of supporting
evidence


RCTs without important limitations or
overwhelming evidence from
observational studies
RCTs with important limitations
(inconsistent results,
methodological ﬂaws, indirect or
imprecise) or exceptionally strong
evidence from observational
studies
Observational studies or case series

1A/strong recommendation, highquality evidence

Beneﬁts clearly outweigh risk and
burdens, or vice versa

1B/strong recommendation,
moderate quality evidence

Beneﬁts clearly outweigh risk and
burdens, or vice versa

1C/strong recommendation, lowquality or very low-quality
evidence
2A/weak recommendation, highquality evidence

Beneﬁts clearly outweigh risk and
burdens, or vice versa
Beneﬁts closely balanced with risks
and burden

RCTs without important limitations or
overwhelming evidence from
observational studies

2B/weak recommendation,
moderate-quality evidence

Beneﬁts closely balanced with risks
and burden

2C/weak recommendation, lowquality or very low-quality
evidence

Uncertainty in the estimates of
beneﬁts, risks and burden; beneﬁts,
risk and burden may be closely
balanced

RCTs with important limitations
(inconsistent results,
methodological ﬂaws, indirect or
imprecise) or exceptionally strong
evidence from observational
studies
Observational studies or case series

Implications
Strong recommendation, can apply
to most patients in most
circumstances without reservation
Strong recommendation, can apply
to most patients in most
circumstances without reservation

Strong recommendation but may
change when higher quality
evidence becomes available
Weak recommendation, best action
may differ depending on
circumstances, patients’ or social
values
Weak recommendation, best action
may differ depending on
circumstances, patients’ or social
values
Very weak recommendations; other
alternatives may be equally
reasonable

Note.RCTs Randomized controlled trials.

Literature search strategy

References

An initial literature was searched using MEDLINE (OVID:
1980 through June 2010), Embase (OVID: 1980 through June
2010), HealthStar (1980 through June 2010), the Cochrane
Library (OVID: Issue 1, 2009), the Canadian Medical Association InfoBase, and the National Guideline Clearinghouse. Reference lists of related papers and recent review articles were
also scanned for additional citations. The literature search was
repeated in 2015 (through to August 24, 2015), in order to
include the most recent literature. Major relevant guidelines
published during the review period in 2016 were also incorporated into the document.3

1. Brouwers M, Kho ME, Browman GP, et al. for the AGREE Next Steps
Consortium. AGREE II: Advancing guideline development, reporting
and evaluation in healthcare. CMAJ. 2010;182:E839–42.
2. Guyatt G, Gutterman D, Baumann M, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: Report from
an American College of Chest Physicians Task Force. Chest
2006;129:178–81.
3. Sterni LM, Collaco JM, Baker CD, et al. An ofﬁcial American Thoracic
Society clinical practice guideline: Pediatric chronic home invasive ventilation. AJRCCM 2016; 193(8):16–35.

Section 2: Initiation of long-term mechanical
ventilation and transition to home

Study selection criteria

Introduction

Articles were selected for inclusion in the systematic review of
the evidence if they reported data on the role of HMV in
children.

Despite its widespread use there remains very little comparative
literature on the precise indications and patient selection process, timing, or optimal methodology for successful initiation
of HMV. This is reﬂected in the marked variability in frequency, types of patients and patterns of HMV reported
between different centers, while conditions deemed appropriate
for HMV continue to evolve. What literature there is generally
describes which individuals were placed on long-term ventilation (LTV) at home, how ventilation was initiated, and some
outcome data (the majority of this data including all ages, with
relatively little pediatric-speciﬁc data). Most programs have
developed their own criteria and protocols for initiation of
home ventilation based largely on empiric experience.
Although these protocols are generally fairly similar, being
based on similar experience and therapeutic goals, there is still
a lack of agreement, and even less objective data, as to precisely

Critical appraisal
The strengths and weaknesses of the evidence were carefully
considered in the generation of the recommendations.
Although the majority of the evidence in this topic area is modest, the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to
inform the generation of recommendations and critically
appraise the strength of the evidence.2 When no evidence was
available, the committee made a recommendation when consensus was reached; the recommendation was subsequently
identiﬁed as such (Table 1).
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who would beneﬁt from long-term HMV. These protocols generally outline the training that is needed, and the equipment
needed for the safe transition of the child to the home. Driven
by costs, recognition that long-term institutionalization is a far
from ideal environment for both child and family, and development of technology that allows for the children on long-term
ventilation to be safely cared for at home, in almost every program the stated goal is for LTV to occur within the home environment. Given that many of these children, by deﬁnition, are
facing life-limiting illnesses, and that caring for these children
at home has a huge impact on family ﬁnances, and family functioning, the relative absence of objective evidence providing
support for these protocols is a signiﬁcant deﬁcit in our
knowledge.
Key evidence
Initiation of ventilation
1. Indications for initiation of HMV: Several criteria have
been suggested as indications for initiation of HMV.
a. Prolongation of life.
i. Noninvasive ventilation (NIV). The beneﬁt of
noninvasive ventilation has been well established
in speciﬁc populations through cohort studies
showing increased survival compared to the natural history of the disease without support.1–4 To
date there have been 2 RCTs performed looking
at this. One study that evaluated “prophylactic”
initiation of NIV was terminated early because
of a 4-fold increase in mortality rate in patients
on NIV.5 However, there have been signiﬁcant
methodological issues raised with this study and
it is not clear whether these patients had already
developed sleep disordered breathing at the time
of initiation. A second smaller RCT in children
with various neuromuscular or chest wall diseases and nocturnal hypoventilation, randomized to either NIV or spontaneous breathing at
night showed no change in mortality. However 9
of 10 controls required institution of ventilatory
support within an average of 8.3 months. In
addition, patients with nocturnal hypoventilation will progress to daytime hypercapnia within
12–24 months.5 Given the signiﬁcant established
increase in prolongation of life in cohort studies,
further RCT looking at this question would not
be ethical.
ii. Invasive ventilation. For a child in end-stage
respiratory failure in whom noninvasive ventilation, is not an option, invasive ventilation
remains the only option for long-term survival.
Reasons, NIV may not be an option include: 1)
ventilator support is required for > 16 hours a
day and the child is not a candidate for mouthpiece ventilation; 2) ventilation cannot be managed with NIV; oral secretions or uncontrollable
gastroesophageal reﬂux disease prohibit the safe
use of NIV; a mask interface cannot be tolerated.

The decision to proceed with invasive ventilation
via tracheostomy involves a discussion surrounding the individual’s expected outcome, and
QoL. This obviously precludes the performance
of randomized control trials.
b. Quality of Life.
i. The effect of HMV on QoL is discussed in Section 3 Ethics and in the disease speciﬁc sections.
c. Prevent Deterioration.
i. Prevention of either deterioration in pulmonary
function or respiratory exacerbations. Several
studies have shown that initiation of NIV fails to
prevent subsequent deterioration in pulmonary
function.6,7 NIV does, however, reduce the probability of requiring readmission, at least within
the year following its initiation.7
2. Identifying the long-term home mechanical ventilation
(HMV) candidate: Children who are being considered
for HMV have life-limiting conditions. There is, however, very little documentation as to the process to be
used to identify the individual patient’s, as well as their
families’, suitability for placement on HMV. HMV
may have a huge impact on not only the child’s QoL
and life expectancy, but also the entire family’s QoL,
free time, and ﬁnancial well-being.8–10 This is further
compounded by the marked variability in resource
availability, not only within the community but also
between families. Protocols are needed that address all
of these issues prior to initiation of ventilation, with
initiation of ventilation occurring as part of a structured plan.
a. Screening. There is good evidence that in children
with progressive neuromotor or pulmonary disease
there is a predictable evolution in their respiratory
failure.11 It is also well recognized that this can be an
insidious process (obviously being altered or hastened
by respiratory infection or other impairments of
respiratory function). Patient symptoms and clinical
evaluation may be insufﬁcient for reliable diagnosis.12
Therefore, objective measures including PSG, oximetry and capnography are required. See Section 8 for
more details.
b. Location for initiation. Initiation of ventilation can
occur in hospital (ward or intensive care unit (ICU),
in the sleep laboratory, or even as an outpatient, being
dependent not only on the child’s clinical status, but
also on the local resources, particularly the availability
of knowledgeable personnel, and the ability to perform comprehensive monitoring to assess adequacy
of ventilation. Family preferences and capacity for
decision making also need to be evaluated. The one
randomized trial on NIV did show that it could be
initiated just as successfully in an outpatient as in an
inpatient setting.13 It is therefore predicated primarily
by local resources including access to PSG or oximetry/capnography in the community. Of note, the initiation of invasive ventilation will always occur in an
ICU setting.
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c. Ability to care for the child in the home environment. The ability of the family to care for the child
needs to be carefully evaluated. The child should be
medically stable (unless palliative), including the
presence of a stable airway, stable oxygen requirements (usually less than 40%), blood CO2 must be
maintained within safe limits on the home ventilator, and nutritional intake must be adequate to
maintain expected growth and development. All
other health conditions, pain and dyspnea included,
should be well controlled. It also must be feasible to
provide the level of support and intervention that
the child will need at home. There should be no need
for laboratory tests or changes in treatments to
ensure community caregivers can manage the child
in the home environment. There should also be no
changes to the medical plan. The parents need to
understand the long term prognosis and must be
willing and capable to meet the child’s complex
needs in the home environment.14 See Section 3
Ethics for further details.
3. Preparation of family and patient: Families with a child
who has chronic respiratory failure must choose between
accepting long-term assisted ventilation and forgoing
life–assisting technology for their child.13
a. The patient and their family need to have a clear
understanding of the potential beneﬁts as well as
the risks for HMV in their child, either noninvasive or invasive. Most published protocols emphasize the need for the patients and their families to
be given adequate time and information prior to
initiation of HMV to ensure appropriate planning
and ability to facilitate informed consent. The discussion regarding the possibility of HMV should
therefore commence close to the time of initial
diagnosis of the illness, be progressively discussed
as the disease advances, and certainly mentioned
long before imminent respiratory failure.15 Unfortunately, even when the child’s disease has a predictable course and outcome, all too often this
does not occur.15
b. The medical team as well as the patient and family
need to all be in agreement with the decision to move
forward with HMV.
Conclusions
HMV has become an accepted therapy for a variety of diseases. Although multiple protocols exist, these are largely
based on clinical experience, with very little comparative
data to evaluate the optimal methodology and selection criteria. Given the reported prolonged length of stay as well
as the barriers that are reported to delay discharge, we
have outlined below the key components of the process for
initiating and discharging a child on LTV. These considerations are essential to facilitate a timely and safe transition
from hospital to home (see Appendix 1 in the source documents available at www.respiratoryguidelines.ca/guideline/
home-ventilation-children).
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Recommendations for initiation of long-term mechanical
ventilation at home
The following recommendations are based on limited evidence
from studies and the use of expert consensus of the HMV
expert panel.
Initiation of long-term ventilation in children
1. Each institution caring for children at risk of respiratory failure should establish a screening protocol (suggestions: symptoms review, routine polysomnogram
[oximetry and capnography if polysomnogram is not
available, pulmonary function]), for the identiﬁcation
of sleep disordered breathing. (GRADE 1C)
2. Each institution caring for children at risk of respiratory failure should establish protocols for the initiation
of HMV, with initiation of ventilation occurring as part
of a structured plan of care. (GRADE 1C)
3. Wherever possible the patients and their families should
be given sufﬁcient time and information to allow them
to make an informed decision regarding advanced care
planning prior to initiation of ventilation. Initial discussions as to the possibility of HMV should begin at
the time of diagnosis and revisited progressively as the
disease progresses and according to the needs of the
family. (GRADE 1C)
4. A national registry is needed to track which patients are
initiated on HMV, the indications and technologies
employed, as well as patient outcomes, to provide objective data on the exact role and indications for HMV in
individual patients. (Consensus)
Transition to home
Although NIV can often be started outside of a hospital setting,
invasive ventilation is done as an inpatient. The reported range
for length of stay after initiation of invasive ventilation was
wide and ranged between 46 days to 9.6 months.16–23 Barriers
that are encountered during the discharge process can be classiﬁed into eight categories: 1) housing issues (eg, lack of running
water or electricity); 2) funding of equipment; 3) receiving
equipment for the home; 4) social issues related to the family;
5) intercurrent illness of the child; 6) issues with community
caregivers (eg, inconsistent caregivers, lack of training of caregivers in the community) or arranging out of home placements;
7) lack of a coordinated approach to discharge and the absence
of a clear coordinator; and 8) delays in organizational decision
making and attitudes of professionals.17–19,21,24–25 For example,
some parental caregivers have reported that their children
stayed in hospital for prolonged periods of time because professionals did not think the families could cope at home and
others felt that they were safer in hospital.
Ideally, protocols should exist that address these issues prior
to initiation of ventilation, with initiation of ventilation occurring as part of a structured plan, thereby increasing the probability of long-term success. Once the decision has been made to
proceed with HMV, discharge planning should begin immediately. The course in hospital can be subdivided into three main
categories: i) establishing the mechanical ventilation

12

R. AMIN ET AL.

parameters for the transition to home; ii) caregiver training; iii)
discharge planning.
1. Ventilation parameters for the transition to home: As
soon as the patient is deemed medically stable and the
decision has been made to go ahead with domiciliary
HMV, work should begin to determine the appropriate
ventilator model, mode of ventilation and settings. The
patient should be trialed on potential home ventilators to
ensure that their gas exchange can be adequately managed on an appropriate home unit. An early introduction
of the home ventilator will also facilitate adherence and
serve to identify any pitfalls early. For NIV, including
mask ventilation or mouthpiece ventilation, the interfaces also need to be trialed to ensure comfort and effectiveness. For mask NIV, interface leak must also be
assessed and minimized. Oximetry, transcutaneous CO2
measurements, blood gases and bedside assessments can
be used to titrate the settings and maximize the time off
the ventilator in a 24-hour period. Where appropriate
for children receiving invasive HMV, readiness for a
speaking valve should also be investigated. In general, it
is recommended that children are on stable ventilator
settings with adequate gas exchange for 2 weeks prior
to discharge home for invasive HMV and ideally for
48 hours for NIV depending on the fragility of the child.
2. Caregiver training requirements: Caregiver training is
dependent upon several factors.
a. Medical fragility of the child. There is an interrelationship between the medical fragility of the child,
their ability to self-care, and the complexity of the
care they require. This is inﬂuenced by several factors
which include the following:
i. Children who are dependent on ventilation for
survival (failure of ventilatory support will lead
to rapid demise) are more fragile than those who
are able to breathe without assistance on their
own (eg, those with neuromotor disabilities).
ii. Many children may also have other impairments
that require additional technological support,
such as enterostomy feeds, catheterization, etc.
iii. The child can verbalize and is able to instruct the
caregiver on needs.
b. Mode of ventilation (ie, invasive via tracheostomy or
NIV) and hence the complexity of equipment
required has a signiﬁcant impact on the depth of caregiver training required, the most intense being for
children on invasive ventilation. These patients
require caregivers who are knowledgeable not only in
ventilator but also tracheostomy management, with
tracheostomy-related events being a principal cause
of death in these patients.26 Since adverse events can
occur at any time it is generally recommended that a
child with a tracheostomy have “24/7” care by an
awake, alert, trained caregiver.27–29 This requires a
minimum of 2 caregivers identiﬁed who are able and
willing to be trained in tracheostomy and ventilator
care in order to care for the child at home. The length
of the caregiver training program varies, usually in
the order of 6 to 8 weeks (for invasive HMV and less

than 1 week for NIV), but depends on the readiness,
availability, and abilities of the designated caregivers
for training.27–28 The family should also receive support to care for the child in the community by paid
caregivers. However, the number and type of paid
community caregiver hours available to families
varies across regions and provinces. Many families
are therefore forced to rely on other supports, such as
unpaid caregivers, family members, nannies, etc. The
issue facing these families, and the child’s health care
providers, is to ensure that these individuals have sufﬁcient knowledge and education to safely care for
their children. A formal training schedule organized
by the HMV should therefore be in place for all of the
child’s caregivers. Although most programs have similar protocols, there are no validated criteria outlining
the needed knowledge and skills necessary to care for
a child on HMV. Most programs emphasize the need
for a period of care-by-parent as the last step prior to
discharge, when the child remains an inpatient, where
help is nearby if needed, while the family caregivers
are responsible for the ongoing care of the child. In
addition, all family caregivers must be Basic Life Support (BLS) certiﬁed prior to the child’s discharge
home. Close to the time of discharge, the family caregivers should have their knowledge and skills
reassessed.
c. Ability of the child to self-care. Obviously infants and
young children are dependent upon continuous provision of care by adult caregivers. The long-term goal,
however, is for the child to achieve as much independence as their illness and developmental level allows.
Consequently the child should also participate, within
the limits of their abilities, in the training program
and be encouraged to assume as much of a role in
their self-care as they wish and are capable of.
3. Financial considerations: Given the necessity of “24/7
eyes on care by an awake, alert, trained caregiver,”29 one
parent often has to stop working to become the primary
caregiver. This results in a signiﬁcant income loss for the
family. Although most local governments provide some
ﬁnancial support for the required equipment, the relative
contribution to the cost of the ventilator and needed supplies varies across provinces, and is rarely sufﬁcient to
cover all expenses. Furthermore, transportation costs
(eg, wheelchair-accessible vans), costs associated with
mobility devices (eg, wheelchairs) as well as the cost of
extra supplies during illness are all added expenditures
for the family. This inevitably results in a signiﬁcant
ﬁnancial burden to most families.
4. Housing assessment: All children going home on HMV
require a housing assessment to determine suitability,
which includes adequate space for equipment and supplies, including doorways (wheelchair), adaptations for
home oxygen, adequate electrical outlets, telephone
access in case of emergency, functional heating and cooling systems, etc. Ideally the ventilator-dependent child
would have their own room with adequate storage for
supplies and equipment. An evacuation process in case
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of ﬁre should be established. Priority for re-connection of
electricity in the event of power loss should also be
instigated.
5. Community services: The links to the community care
services (eg, home care nursing, rehabilitation services)
should be established well in advance of the discharge
date. The community-based homecare providers should
be identiﬁed early to ensure both that there is adequate
coverage, and that the community caregivers receive adequate training. Potentially relevant factors include:
degree of ventilator dependence, medical fragility (see
2a, above) (will the child awaken or breathe spontaneously if disconnected, use of invasive HMV or NIV),
mode of nutrition, ambulatory or wheelchair assisted,
other health issues, as well as the ability of the family to
cope with the child’s needs.14 Therefore, it is essential
that community partners are identiﬁed as early as possible in the process to prevent discharge delays.
6. Discharge planning: A multidisciplinary assessment
including the family, the patient, intensive care, respiratory medicine, nursing, social work, occupational therapy, physical therapy, respiratory therapy, the primary
care pediatric provider, the community homecare agency
and discharge planning should be performed to identify
the particular needs of the child and family. The interprofessional teams need to be coordinated by one primary case manager. The beneﬁts of a dedicated case
coordinator for a patient have been demonstrated.22 The
case manager needs to act as a liaison between the hospital-based teams and the community care providers.
Some discharge programs will have 2 coordinators—a
community practitioner and a hospital case manager, or
vice versa.14,30 As soon as a decision has been made to
proceed with HMV at home regular multidisciplinary
team meetings should be scheduled every 4 weeks and a
projected discharge date should be set.
For discharge from hospital to home
1. Discharge care plan: A written discharge care plan is
an essential component of a successful discharge from
hospital to home. This should include the clinical
information around ventilator dependence, the underlying disease and prognosis, the current ventilator settings, a plan in the case of acute illness or
deterioration, what to do in case of emergencies, as
well as the names and contact information of the
main health care advisors, as well as emergency services. This treatment plan should be shared with the
family, as well as all necessary local agencies, including ambulance, police, and local utilities. The health
care team must ensure the family has an adequate
mode of transportation to transport the child to follow-up appointments as well as around the community, with an additional caregiver in the vehicle for
children who require ventilation during transit, or
have a tracheostomy. If feasible, a graduated discharge
with a ‘trial run’ at home is recommended prior to
discharge.
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2. Ongoing care: Ongoing follow up and coordinated care
between the local and specialized clinical teams is essential to successfully support the child and their family.29
Ongoing care is provided by a joint partnership between
the primary care provider and the respirologist and
HMV team. This ongoing care is multimodal and may
include any combination of the following: telephone,
telemedicine, home visits, clinic visits, and visits during
hospitalizations for intercurrent illnesses. The family
therefore needs to be aware of the follow-up care plan,
which will depend on the child’s status and needs, and
coordinated with other consultants following the child.
Furthermore, family caregivers need to continue to
receive ongoing tracheostomy and ventilator skills
assessments and retraining.
3. School: Many children with a tracheostomy and invasive
HMV attend school. An emergency plan needs to be
clearly delineated for the child and a mobility plan for
the child around the school needs to be clariﬁed. In addition, a tracheostomy and ventilation-trained caregiver
needs to accompany the child at school and the other
allied health care services the child will receive at school
need to be arranged.
4. Equipment: There is an extensive list of equipment and
supplies needed to care for a ventilated child, both at
home and for travel that should be developed and conﬁrmed by the team. In addition, the source of the equipment as well as the ordering responsibility and necessary
funding needs to be identiﬁed (see Section 2, Full Article,
Appendix 2). Equipment and supplies should be ordered
as early as possible in the transition process to avoid
delays in discharge.
5. Psychosocial considerations: See Section 13 for psychosocial considerations of HMV.
Conclusions
There has been a signiﬁcant increase in the number of medically complex children requiring long-term ventilation in the
past few decades. The overwhelming majority of children
receiving HMV are successfully discharged from the hospital to
home. The success of home ventilation programs is in large
part due to the coordinated, comprehensive multidisciplinary
approach driven by a central, hospital-based case manager and
includes dedication and commitment by family and community caregivers.
Recommendations for transition to home
The following recommendations are based on limited evidence
from 10 studies and Consensus of the HMV expert panel.
Transition of children on long-term ventilation to home
1. Each institution caring for children on long-term
mechanical ventilation at home should collaboratively
develop a written care plan, with the family, health
care providers in the referring center, as well as the
community health care/homecare team involved in the
patient’s long-term care. (GRADE 1C)
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2. Lines of communication need to be established between
regional centers and the community caregivers, with
clear outlines as to respective responsibilities both for
routine follow up, and emergencies associated with
unexpected events such as illness or equipment failure.
(GRADE 1C)
The following recommendations have been adapted from the
adult home mechanical ventilation guidelines and are based
on the consensus of the expert pediatric HMV panel.
3. Each institution discharging a child home should have
a designated case coordinator to streamline the discharge process, minimize the length of stay, and ensure
a safe transition home. (Consensus)
4. The patient should be medically stable with a need for
a level of monitoring or treatment interventions that
can be managed at home. (Consensus)
5. The patient and the family must be highly motivated.
(Consensus)
a. The family is willing/able to ensure provision of “24/
7 eyes on care” for all invasively ventilated children
and for children receiving NIV that are deemed medically fragile and in need of this level of care at
home.
b. The family is aware that the discharge destination is
home, not a long-term care facility.
c. The family is willing to provide needed supports
(ﬁnancial, physical, emotional).
6. The patient must have a home that is safe for a child
requiring long-term mechanical ventilation. (Consensus)
7. The patient must have sufﬁcient caregiver support.
(Consensus)
a. Two primary, family caregivers identiﬁed and
trained.
b. Sufﬁcient community caregivers identiﬁed and
trained to provide parental support. In the absence
of private funding, sufﬁcient government funding
available to pay for these caregivers.
c. Sufﬁcient out-of-home respite needs to be available.
d. Family caregivers in agreement that they are responsible for the majority of the care.
8. Each institution or HMV program caring for these children must ensure the patient has the appropriate
equipment and supplies needed for long-term ventilation. (Consensus)
a. There must be a list of needed equipment and the
institution or HMV program must ensure that it is
ordered and delivered to the home or is in use.
b. Sources for ongoing required supplies need to have
been identiﬁed.
c. There should be a clear protocol in place for maintenance and replacement of necessary equipment.
9. There must be comprehensive initial competency-based
training regarding the knowledge and skills needed to
care for a child using HMV, plus ongoing education
and training for patient and caregivers once they are in
the home setting.29 (Consensus)
a. The initial education is organized to accommodate
learning, practice, and inclusion of caregivers in the
care routine as early as possible.

10. The patient must have access to health care support in
the community. (Consensus)
a. Follow-up care is available as appropriate (tracheotomy tube changes, ventilator reassessments, interface
ﬁt and skin breakdown, adherence and assessment of
the ongoing effectiveness of the ventilator support).
b. Medical follow-up to allow for appropriate changes
to the mode of ventilation (ie, from invasive to noninvasive and vice versa, from continuous to nocturnal and vice versa).
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Section 3: Ethics of initiation of long-term mechanical
ventilation at home in children
Introduction
The decision to initiate long-term ventilation in children is usually based on the conclusion that it is required to mitigate the
underlying disease; prolonging a child’s life and sustaining
quality of life (QoL) are chief among the goals of instituting
this technology. Indeed commencing long-term ventilation
when the option is deemed medically appropriate typically
results in prolonged survival, whether invasive (eg, tracheostomy) or noninvasive (NIV) techniques are employed.1–3
Nonetheless, health care practitioners, patients, and families
must consider more than just “will this intervention prolong
life?” before a decision to initiate long-term ventilation is
reached. An approach to ethical decision making regarding initiation of long-term ventilation is critical.
Key evidence
A review of the medical literature on the ethical issues associated with long-term ventilation for children at home revealed a
paucity of data. The evidence suggests that a shared decision
making approach is preferred by most families faced with the
decision of long-term mechanical ventilation in their children.1,4 Shared decision making occurs when health care practitioners assist families by exploring goals of care and making
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recommendations in line with those goals in order to reach a
consensual decision. As with any medical decision for children
who lack capacity, the child’s best interests should guide decision making; however the incapable child should be involved to
the extent that he or she is able and willing to participate, with
their wishes being an important consideration.5,6 In contrast,
consent must be obtained from the child who is deemed to
have the capacity to make such a decision on their own. Early
advanced care planning discussions with families when the possibility of long-term mechanical ventilation is foreseeable
encourages them to think about their wishes prior to the time a
decision is required, ideally removed from a crisis.7 The diagnosis of a life-limiting condition or the decision to pursue an
approach focused on comfort does not prohibit the use of
mechanical ventilation at home; these interventions have not
only been shown to help some children live longer, they may
also help them to feel better and engage in meaningful activities.8–11 Mechanical ventilation can also be used to help transfer
children home for end-of-life care, where it can then be compassionately removed leading to a peaceful death.12,13
Conclusion
Numerous ethical issues are associated with the consideration
of implementing long-term mechanical ventilation at home in
children. Despite the relative deﬁciency of medical literature on
this topic to guide an evidence-based approach, long-standing
ethical norms and standards to decision making for children
should be used by patients, families and members of the health
care team as they contemplate embarking on the use of
mechanical ventilation at home. The use of this technology
depends largely on the goals of care expressed by the patient
and/or family. HMV may be used within the context of goals
focused on palliation and comfort. Clinicians have a duty to
help decision-makers appreciate: the ability of mechanical ventilation at home to achieve their goals; the challenges, ﬁnancial
and otherwise, that come with this intervention; and a clear picture of what life may look like once this path is taken. Lastly,
this chapter explores the potential application for mechanical
ventilation in children at home within the context of goals
focused on palliation and comfort.
Recommendations for ethics of long-term mechanical
ventilation at home in children
1. The initiation of long-term ventilation in a child should
be made using a shared decision-making model, in
which health care practitioners assist children and their
families by reaching a consensual decision together,
after the health care team has informed them about all
options available under the child’s speciﬁc circumstances. (Consensus)
2. Whenever possible, the child should be involved in all
aspects of decision making, in a developmentally appropriate way, to the extent that he or she desires and to
the extent possible. When the child is deemed capable of
making the decision to initiate long-term ventilation,
ultimately his/her consent is required. When a child
lacks capacity to decide about the initiation of long-
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3.

4.

5.

6.

7.

term ventilation, parents (or other legal guardians)
must do so by considering the child’s best interests and
perceived QoL within the framework of family-centered
care. (Consensus)
The health care team should inform the child and family about all options available under the circumstances,
and support them to reach a decision that is consistent
with their goals and preferences. (Consensus)
Health care providers should clearly explain regional
realities about resource limitations and convey how
such constraints might impact the child, the parents
and the family when facing a decision regarding
HMV. Health care providers should not prohibit the
initiation of long-term ventilation based solely on
resource limitations; the best interests of the child
must remain at the center of the health care team’s
consideration. (Consensus)
When the best interests of the child are not clear, the
health care team should act in accordance with the
wishes of the family. However, health care providers
need not acquiesce to home ventilation when it will not
achieve realistic or reasonable goals of care or when it
is outside of the standard of care. (Consensus)
Advanced care planning should begin early for children
in whom long-term mechanical ventilation at home is
foreseeable. (Consensus)
Mechanical ventilation may have a role within the
context of a palliative plan of care. It has been successfully used to help some children with life-limiting conditions be more comfortable and achieve meaningful
goals. With adequate planning and resources, mechanical ventilation may also be used to transport a child in
order to facilitate a compassionate death at home.
(Consensus)
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Section 4: Home monitoring and follow-up of longterm mechanical ventilation at home in children
Home monitoring
Introduction
Children on HMV are at risk of acute deteriorations and
adverse events. There is an increasing number of infants and
children now cared for with mechanical ventilation in the
home environment.1–8 Hence there is a need for monitoring
and close follow-up is required, especially early after discharge
home. An awake and alert trained caregiver 24 hours a day and
7 days a week will provide the ﬁrst line monitoring of a child
receiving ventilation in a situation where interruption of ventilation is anticipated to lead to an adverse event including all
invasively ventilated children as well as those on NIV that are
medically fragile (at risk of imminent adverse events if the NIV
mask isdisplaced or equipment malfunctions).9 Although caregivers represent the ﬁrst line of monitoring for the child to
identify acute events that could be potentially life-threatening,
monitoring equipment is often used in addition to the built-in
alarms on the home ventilators.
Key evidence
Retrospective reviews of cohorts usually from a single institution, some based on large, others on small numbers of patients,
comprise most of the evidence for the risk of death and adverse
outcome for children using HMV. In the absence of high-quality evidence, the strength of the recommendations were determined by consensus within the group.
Evidence comes from 30 cohort studies.1–31 There is ample
evidence that indicates that infants on HMV are at risk of sudden death due to bleeding, infection, decannulation or disconnection from the ventilator. The evidence comes from 30
cohort studies with a total mortality of 2.4%. Thus, there is the
indirect evidence that adequate monitoring should be done.
While it is counter-intuitive one might ﬁnd it surprising that
accidental decannulation or ventilator disconnection is frequently not detected by the low-pressure alarm on the ventilator. It has been reported that during disconnection from the
ventilator, the ventilator hub might be sufﬁciently obstructed
by the patient or by bedding material to allow creation of
enough back pressure to not trigger the alarms.10 In addition,
when a child has an accidental decannulation, depending on
the ventilator settings and characteristics (pressure and ﬂow), a
sufﬁcient drop in pressure may not occur. This is more likely
with smaller tracheotomy tubes because of the higher resistance. One study simulated tracheotomy tube decannulation in
an experimental setting with tracheotomy tubes ranging from
3.0 to 6.0 mm of internal diameter (ID).11 The low inspiratory
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pressure alarm was not triggered during simulated decannulation with small tracheotomy tubes (<5.0 mm ID). These ﬁndings are the basis for the recommendation of always using
external monitors as well as setting the low minute ventilation
alarm in addition to using external monitors. The consensus is
also that patients not able to awaken or breathe spontaneously
if disconnected from the ventilator require direct monitoring
by a trained caregiver and should also be considered for external home monitoring.
There are several published large series of children using
HMV from around the world reporting on the use of external
monitors for this population, but details are scarce. In some of
these programs, including Munich, Germany,12 the Children’s
Hospital of Los Angeles, USA,13 and the Hospital for Sick Children in Toronto, Canada,7 all patients on invasive mechanical
ventilation use pulse oximeters at home. For other programs,2,14 although the proportion of children under monitoring is also at or near 100%, other means of monitoring are used
(eg, cardiorespiratory monitors, end-tidal CO2 monitors, continuous direct observation by a nurse), although much less
often than pulse oximeters.
Monitoring of oxygenation status is, in theory, better than
that of electrocardiogram (ECG) and thoracic movement
because obstructive events will not be detected with monitors
that use variations in thoracic movement for respiration detection, and signiﬁcant hypoxemia will precede bradycardia.14
This is the basis for the recommendation against the use of
home cardio-respiratory monitors in which respiration is
detected with the transthoracic impedance technique. The old
generation of oximeters was, however, renowned for false
alarms16; the new generation of oximeters trigger fewer false
alarms and are well suited for the home environment.17–19
However, no evidence except consensus is available for the use
of oximeters to monitor children using HMV. In addition, all
monitoring equipment as well as the ventilators need to
undergo regular maintenance.32–33
Conclusions
Most large studies of children using HMV report mortality due
to accidental decannulation, ventilator disconnection or tracheostomy-related deaths. Home surveillance by health professionals in addition to the use of external monitors are strategies to
decrease mortality and morbidity not due to progression of the
underlying condition.
Recommendations for home monitoring in children using
long-term mechanical ventilation at home
1. An awake and alert trained caregiver 24 hours a day
and 7 days a week will provide the ﬁrst-line monitoring
of a child receiving ventilation in a situation where
interruption of ventilation is anticipated to lead to an
adverse event including all invasively ventilated children as well as those on NIV that are medically fragile
(at risk of imminent adverse events if the NIV mask is
displaced or equipment malfunctions). (Consensus)
2. The built-in alarms of the home ventilators should be
adjusted for each patient to maximize safety and minimize nuisance alarms. (Consensus)
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3. The low minute ventilation alarm and disconnect alarm
should be set optimally to maximize the detection of circuit disconnection and decannulation. (Consensus)
4. For children receiving invasive ventilation via tracheostomy at home through a tracheotomy tube that is
smaller than 5 mm ID, an external monitor should be
used in view of the potential failure of internal monitors
to detect circuit disconnection and decannulation in
addition to an awake and alert trained caregiver.
(Grade 1C)
5. Patients not able to awaken, breathe spontaneously
and/or at risk of adverse events if disconnected from the
ventilator should have an external home monitor in
addition to an awake and alert trained caregiver.
(Consensus)
6. Home cardio-respiratory monitoring with respiration
detected with transthoracic impedance techniques
should not be used as external monitors as they fail to
detect obstructive events. Similarly, caregivers should
not rely on the detection of bradycardia with these monitors because bradycardia is a very late event. (Grade 1C)
7. Pulse oximeters with downloadable memory should be
the monitor of choice for patients identiﬁed as needing
an external home monitor. (Consensus)
8. Recurrent alarms should be dealt with promptly to correct the problem, whether equipment-related or patientrelated. (Consensus)
9. Routine periodic maintenance of the home ventilators
and monitoring equipment is recommended as per the
manufacturer’s recommendations.
Follow-up care
Introduction
Follow-up care involves the ongoing reevaluation for the child
on HMV, which includes an assessment of clinical status, the
effectiveness of ventilation, and the maintenance and evaluation of the equipment. This can be done using a combination
of clinic visits, in-home evaluation and telemedicine.
The frequency of follow-up visits for children on HMV is
variable. It will depend on several factors including: the baseline disease and its severity, the stability of the child, the
expected natural course of the disease process, the distance
between home and the follow-up facility, the availability of
follow-up care in the community (interprofessional team), the
distance to a specialty center, and the support the parents are
receiving for the care of their child (nursing support in the
home). Respiratory requirements are dynamic in children due
to growth, level of activity (depending on the disease) and the
natural history of the underlying condition. Clinical information from visits does not always predict whether a change in
respiratory support will be required and reevaluation of the
support is needed on a regular basis.
Key evidence
In the few published statements from Health Authorities and
Clinical Practice Guidelines,20–21 we found no clear evidencebased recommendations concerning the frequency and content
of follow-up visits, the use of clinic, home or telemedicine visits,
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or the evaluation of ventilation effectiveness for children using
HMV. Therefore, any recommendations will be based on consensus among experts. Recent randomized trials comparing clinic
and telemedicine visits are available for the adult population on
HMV27–29 and 3 publications have reported the telemedicine
experience in children. The use of telemedicine compared favorably to clinic visits and was acceptable to the patient and family
and user-friendly,27,29–31 it decreased admissions, clinic visits or
emergency room visits27–30 and was cost-effective.28–29
Clinical practice guidelines have suggested a global reassessment every 6 to 12 months.20,21 It is usually suggested that the
ﬁrst assessment occur in the ﬁrst month and no later than
3 months after discharge home. After the ﬁrst visit, the interval
between assessments will depend upon the status of the child
and the disease process.
Information on the optimal ways to evaluate the effectiveness of ventilation in children using HMV was available from 3
consensus statements21,23,24 and 2 publications have evaluated
the frequency of changes in ventilator settings following recordings done in hospital or at home.25,26 Ideally, each home ventilator (invasive or NIV) should have downloadable memory to
allow: assessments during clinic visits or at home of the effectiveness of ventilation; review of the logs of alarms, their type
and frequency; and to enable reviewing of the patient’s ventilator adherence. A home assessment should entail at a minimum
a review of the oxygen saturations measured by pulse oximetry
(SpO2) and end-tidal or transcutaneous carbon dioxide recordings overnight. Performing a PSG for reassessment of the effectiveness of ventilation is usually recommended on a 6-month
or yearly basis.23
Recommendations for follow-up care for children using longterm mechanical ventilation at home
Given the paucity of published data and the lack of recent
clinical practice guidelines, the following are consensus
recommendations.
1. The ﬁrst visit and the frequency of subsequent visits
should be tailored to the child and family’s need. The
ﬁrst visit should occur within 3 months after discharge
home based on patient acuity and subsequent visits
should be at a minimum of every 6 months. (Consensus)
2. Effectiveness of ventilation should be assessed regularly.
(Consensus)
a. A polysomnogram (ideal) or an assessment of oximetry and capnography, if polysomnogram is not available, should be performed yearly.
b. The home ventilator (invasive or noninvasive NIV)
should be downloaded during clinic visits or at home
to review the effectiveness of ventilation as well as to
review the logs of alarms, their type and frequency,
and to review adherence.
3. Quality of Life and/or other parameters of family and patient
well-being should be regularly measured. (Consensus)
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Section 5: Airway clearance in children using longterm mechanical ventilation at home
Introduction
Airway patency and adequate cough clearance are required in
order to maintain adequate ventilation, but are compromised
in patients with respiratory muscle weakness and those receiving invasive ventilation via tracheostomy, where adequate glottic closure is impaired. Recurrent atelectasis and pneumonia
are frequent complications in these patients.1,2,3,4,5 Supportive
airway clearance techniques6 assist with removal of secretions
from the lungs and airways.3,6–9 Noninvasive airway clearance
strategies (1) increase inspired lung volume to reach maximum
insufﬂation capacity (MIC), through Lung Volume Recruitment (LVR) or “breath-stacking”, (2) increase expiratory force
in the expulsive phase of cough with manually assisted coughing, and/or (3) accelerate expiratory airﬂow through application of positive and negative airway pressures with mechanical
in-exsufﬂation. Physiotherapy techniques such as percussions
and vibrations assist with mobilization of secretions from the
distal airways. Agents that alter viscosity of secretions may aid
with airway clearance. Finally, in individuals with tracheostomies, suctioning is often also applied, to clear secretions from
the large airways.
Key evidence
LVR is the most commonly employed technique to assist with
cough and airway clearance in individuals with respiratory
muscle weakness. Insufﬂation may also help to maintain chest
wall range of motion and lung compliance.7 LVR improves
cough efﬁcacy in adults and children with neuromuscular disease.3,10 It may be applied in individuals at risk of requiring or
already receiving NIV. LVR techniques include: 1) glossopharyngeal breathing (air stacking or “frog breathing”),11,12 2) insufﬂation with a self-inﬂating resuscitation bag and patient
interface with a one-way valve6 with or without a manually
assisted cough,7,13–15 or 3) mechanical in-exsufﬂation by delivering positive pressure breaths, followed by a rapid negative
pressure to mimic a cough.1,3,16 Most studies performed to date
have incorporated LVR as an integral part of an overall
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approach to care, making it difﬁcult to assess its impact alone
on clinical course.17
Optimal frequency of usage of LVR and mechanical inexsufﬂation is not known, although it has been shown that during the ﬁrst 24–36 hours of an intercurrent illness, individuals
with weak respiratory muscles experience a decline in pulmonary function18 and airway clearance techniques are therefore
critical at these times to prevent morbidity and mortality. The
patient populations who will beneﬁt most from these interventions have not been clearly determined. Lung and chest wall
compliance, as well as bulbar function determine the degree to
which LVR can be performed.17,19 LVR techniques may be
most applicable to patients with neuromuscular or chest wall
disease but may also beneﬁt those with obstructive airways
diseases.20
LVR has been recommended by Bach and Finder as the
“standard of care” for neuromuscular patients.1,9,17,21–25
Although thresholds of FVC < 40–60% predicted,9,26 peak
cough ﬂow (PCF), and maximum expiratory pressure have
been suggested as guidelines for the initiation of LVR, ranges
provided are for adults and cannot necessarily be applied to
younger children.9,25
There are no comprehensive, prospective long-term studies
on the use of LVR in ventilator-assisted children and youth.
Most studies were performed primarily in adult patients,27
although some included small numbers of children with neuromuscular disease. Of these studies, 3 looked at the effect of
mechanical in-exsufﬂation. One case series, which studied
mainly adults, demonstrated an improvement in MIC, despite
a decrease in vital capacity, over 0.5–24 years of follow-up in
282 patients with neuromuscular disease.28 A similar protocol
using noninvasive positive pressure ventilation (NIV) and LVR
has been used in a prospective cohort study to avoid intubation
and death in episodes of acute respiratory failure in 79.2% of
the cohort of adults with neuromuscular disease.5 In a largely
pediatric population there has only been 1 retrospective review
of long-term regular (once a day to every 4 hours) use of
mechanical in-exsufﬂation in 62 individuals with neuromuscular disease and impaired cough (age range 3 months to
28.6 years), with a median duration of 13.4 months29 6% of
participants experienced an improvement in chronic atelectasis
and 8% noted a reduction in frequency of pneumonias,
although the number of acute lower respiratory tract infections
was too small to permit meaningful comparison with a pretreatment period. In an analysis of a patient registry for Spinal
Muscular Atrophy Type I, the use of a mechanical in-exsufﬂation device had a signiﬁcant independent effect in reducing
death.30 Excellent tolerance ( 90%) of LVR has been reported
in children.7,29,31 Optimal positive and negative pressure settings for manual and mechanical in-exsufﬂation are not known
and range in the literature from C/¡ 15–45 cm H2O.32 The
British Thoracic Society Guidelines for Neuromuscular Disease
also recommend that mechanical in-exsufﬂation should be considered in very weak children, those with loss of bulbar function
and those who cannot cooperate with manual lung volume
recruitment techniques or in whom the methods are not
effective.44
The use of Chest Physiotherapy techniques, including High
Frequency Chest Wall Oscillation (HFCWO) and Intra-
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Pulmonary Percussive Ventilation (IPPV) are controversial and
not fully established in individuals with respiratory muscle
weakness.6,9,33–38 Similarly, agents that alter viscosity of secretions have not been well studied in children with impaired
cough. On a case-by-case basis, in those with atelectasis, such
treatments may be considered.6 Finally, management of associated comorbidities of the underlying condition that contribute
to impaired airway clearance need to be addressed, including
obesity, aspiration of oral secretions and/or food, as well as gastroesophageal reﬂux.6
For individuals with artiﬁcial airways,39,40 suctioning via
catheter is a method to remove secretions from the large airways. The mechanical in-exsufﬂator can be used to clear secretions from the peripheral airways. Additional adjunctive
treatments to enhance airway clearance in this population
include increasing patient mobility and repositioning,39,41 and
the use of heated humidity.39,40,42 Tracheostomized patients
also require adequate ﬂuid intake to avoid dehydration, which
can result in inspissated secretions. Uncuffed tracheostomy
tubes are preferred over cuffed tubes if ventilation can be provided adequately.
Conclusions
Manual and mechanical in-exsufﬂation for airway clearance
have been shown in observational and cohort studies to
have beneﬁts in individuals with impaired cough. There is a
dearth of pediatric literature in this area. However, there
are no randomized controlled trials to guide clinical care.
While LVR has clear beneﬁts in acute illness, its optimal
role and applications in routine care remain unknown, particularly in invasively ventilated patients. Similarly, additional airway clearance modalities, including IPPV and
HFCWO are not well studied, but may be beneﬁcial in
select patients. Suctioning and mechanical in-exsufﬂation
for some patients remain the standard of care for airway
clearance in tracheostomized individuals.
Recommendations for airway clearance in children using
long-term mechanical ventilation at home
Patients using NIV
1. Airway clearance techniques should be taught to children and caregivers as a preventative strategy in those
with evidence of impaired cough, especially if they have
had episodes of deterioration with respiratory infections. (GRADE 1C)
2. In the absence of contraindications, manual and/ or
mechanical lung volume recruitment techniques should
be introduced for children with impaired cough
(deﬁned by clinical assessment, and/or MEP < 60 cm
H2O and/or PCF in children  12 years < 270 L/min
and/or FVC < 40% predicted. (GRADE 2C)
3. Mechanical lung volume recruitment techniques (ie,
mechanical in-exsufﬂation) should be considered in
very weak children, those with loss of bulbar function
and those who cannot cooperate with manual lung volume recruitment techniques or in whom the methods
are not effective. (GRADE 1C)

4. High Frequency Chest Wall Oscillation (HFCWO) and
Intra-Pulmonary Percussive Ventilation (IPPV) could
be considered for patients with impaired cough with
atelectasis/consolidation, despite use of other airway
clearance techniques. (Consensus)
Patients ventilated via tracheostomy
1. Minimally invasive rather than deep suctioning is recommended when possible. (GRADE 2B)
2. Heated humidity is recommended over heat-humidity
exchangers. (GRADE 1A)
3. Clean, as opposed to sterile, conditions are adequate for
home secretion clearance and suctioning. (GRADE 2C)
4. Mechanical in-exsufﬂation and manual LVR for tracheostomy airway clearance should be considered through
the tracheostomy to complement deep suctioning.
(GRADE 2C)
5. Adequate hydration (optimized ﬂuid intake) is essential
to maintain thin, easily cleared secretions, especially in
infants. (GRADE 2C)
6. High Frequency Chest Wall Oscillation (HFCWO) and
Intra-Pulmonary Percussive Ventilation (IPPV) could
be considered for patients with impaired cough with
atelectasis/consolidation, despite use of other airway
clearance techniques. (Consensus)
7. Mechanical lung volume recruitment (ie, Mechanical
in-exsufﬂation) should be available in the acute setting
in all hospitals that treat children using HMV with the
purpose of preventing deterioration. (Grade 2C).

Contraindications for manual/mechanical lung volume
recruitment techniques see http://www.irrd.ca/education.43

Peak cough ﬂow in healthy children < 12 years of age
may be < 270L/min.26
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Section 6: Long-term mechanical ventilation at home
in chronic lung disease
Introduction
HMV has been used with increasing frequency over the last
25 years among children with chronic lung diseases such as
bronchopulmonary dysplasia (BPD) and cystic ﬁbrosis (CF).
There are no randomized controlled trials of HMV in either
population. The following summary is based primarily on retrospective, observational studies and expert consensus.
Key evidence
Bronchopulmonary dysplasia
In Canada there is growing recognition that HMV through a
tracheostomy is feasible and can be achieved safely in children
with BPD. Studies in the US and Europe have observed survival
of 81%–95%1–3 among these children, with 67%–79% being
successfully weaned from ventilation before age 5 years.1,3 Outcomes are better among children without concurrent additional
congenital heart disease or central nervous system insults.2,4
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The perceived beneﬁts of HMV for children with BPD,
include an earlier discharge from hospital, and possible
improvement in social and neurodevelopment for the child as
well as overall quality of life (QoL),5 but there is little evidence
to support these notions. Furthermore, there is a paucity of
studies to determine the optimal timing for consideration of
tracheostomy in these children. HMV has been shown to
reduce health care costs6,7 for children with BPD in other countries, but this has not been studied in Canada.
Though there is no consensus on the best type of home ventilator to use in infants with BPD, it is recommended that
patient-speciﬁc adjustments to ventilator parameters should be
made, based on work of breathing and gas-exchange, as measured through capillary blood gases, pulse oximetry, and endtidal carbon dioxide (CO2) monitoring.8 There is little
published on speciﬁc techniques for weaning of HMV but consensus recommendations include regular monitoring of oxygen
saturation, end-tidal CO2, and capillary blood gases, maintenance of growth and activity, as well as routine screening for
pulmonary hypertension during weaning.7,8
Cystic ﬁbrosis
The efﬁcacy of NIV in CF patients remains controversial
as the evidence remains mixed. Most studies of NIV outcomes in CF involve samples including both adult and
pediatric patients. Such studies have demonstrated that
nocturnal nasal bilevel intermittent positive pressure ventilation is well tolerated, unloads respiratory muscles,9
reduces respiratory rate, improves quality of sleep and
increases capacity to perform activities of daily living.10 In
addition to symptom management, NIV may also stabilize
lung function decline.11,12
There is evidence that NIV improves respiratory acidosis
and dyspnea,13–15 and a recent Cochrane review concluded that
in CF patients with moderate to severe disease, NIV, in addition to oxygen, may improve gas exchange more than oxygen
alone.16
There is no consensus on when to initiate NIV in CF
patients, though pulmonary exacerbation is the most common indication, followed by stable, persistent diurnal
hypercapnia. NIV has been used in adult CF patients in
chronic respiratory failure as a bridge to transplant,
thereby improving survival once lung transplantation
occurs, and one pediatric retrospective cohort study
reported on 6 children who were using NIV just prior to
successful lung transplantation.12

Conclusion
There is evidence to suggest that HMV for children with
chronic lung diseases can be used safely and is well tolerated.
While delivery of ventilation through a tracheostomy is recommended for infants with BPD, nocturnal NIV is the preferred
mode for children with CF. More pediatric-speciﬁc studies are
needed to identify the best timing for initiation of HMV for
children with chronic lung disease, how best to titrate or wean
support, as well as the long-term health beneﬁts of both NIV
and invasive ventilation at home in children.

Recommendations for long-term mechanical ventilation at
home in chronic lung disease
1. Consider tracheostomy and HMV in children with
bronchopulmonary dysplasia with stable pressure settings that are achievable with a home ventilator, with
an FiO2 < 0.4 and children who are otherwise medically stable, demonstrating stable growth, and can be
safely transported. (Grade 1C)
2. Children with bronchopulmonary dysplasia who are
being considered for home ventilation should be discharged with a tracheostomy C ventilator (rather
than NIV). Adequacy of ventilation should be determined before discharge based on work of breathing
and optimal gas exchange as measured through capillary blood gases, pulse oximetry, and end-tidal
CO2 monitoring. (Grade1C)
3. Weaning of home ventilation should be considered once
oxygen saturations are consistently > 95% and the child
is demonstrating growth and health stability. (Grade 1C)
4. Home NIV should be considered in Cystic Fibrosis
patients who have evidence of any of the following:
sleep-disordered breathing (SDB), hypercapnia, nocturnal desaturations, increased work of breathing, poor
exercise tolerance, and a decline in FEV1 to below
< 30% predicted. (Grade 1C)
5. Efﬁcacy of NIV in a Cystic Fibrosis patient can be evaluated by blood gases, nocturnal oximetry, PSG, exercise
tolerance, patient comfort, and quality of life. (Grade 1C)
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Section 7: Long-term mechanical ventilation at home
in spinal muscular atrophy
Introduction
Spinal Muscular Atrophy (SMA) is a recessively inherited neurodegenerative disorder of the anterior horn cells of the spine.1
The International Spinal Muscular Atrophy Consortium
(ISMAC) in 1992 established the presence of 3 types of SMA
characterized by varying clinical severity2: Type I (also known
as Werdnig-Hoffman disease), is diagnosed between birth and
6 months of age and deﬁned by the inability to sit independently. The majority of such patients have a life expectancy
< 2 years.3 The onset of SMA Type 2 is before 18 months.
Patients are able to sit independently but will never stand; death
generally occurs after the age of 2.2 Type 3, is the mildest form
of the disease with onset after 18 months of age with affected
children being able to stand and walk independently; life expectancy is normal.6
Key evidence
There are no randomized controlled trials of ventilatory management for children with SMA in the pediatric literature. The
following is based on prospective or retrospective case control
and cohort studies with the majority of the evidence focusing
on various aspects of NIV.
NIV
The goals of NIV include providing improved quality of life
(QoL) for patients and families, adequate inspiratory chest wall
expansion, normalization of nocturnal and diurnal gas
exchange, prevention of respiratory infection, hospitalization,
and improvement of overall survival.4–15 There have been 5
studies assessing the efﬁcacy of NIV for the treatment of SDB
in children with SMA.5–9 Improvements in the respiratory disturbance index and sleep architecture have been reported in
patients. Symptomatic beneﬁts in sleep quality, headaches, daytime sleepiness, appetite, concentration, and sweating have also
been noted.5 NIV has been shown to reduce hospital as well as
intensive care unit stays.7 There were 85% fewer days in hospital and 68% less ICU days in the year following NIV initiation
as compared to the preceding year in a mixed population of 15
children with neuromuscular conditions, some of whom had
SMA. Although children with SMA Type 1 on NIV required
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multiple admissions during infancy, they had fewer admissions
with increasing age.8,10–11 Registry data indicate that ventilation
(invasive or noninvasive) for greater than 16 hours per day in
addition to use of the mechanical in-exsufﬂation (MI-E) device
and gastrostomy tube feeds are the 3 factors that signiﬁcantly
improve survival after controlling for demographic and clinical
care variables.3 In the group of patients with later presentation,
improved survival on NIV is seen; in some cases, NIV can ameliorate symptoms as well as extend life.3,8,10–11 The use of NIV
in SMA is generally considered safe, when used with adequate
pressures and correct mask placement, and has been shown to
have no deleterious effects on patient hemodynamics.13 However, potential limitations to NIV include difﬁculty identifying
a well-ﬁtting interface, particularly for infants, as well as skin
irritation and/or breakdown, and midface hypoplasia. In addition, gastric distension and emesis are recognized risks, which
can subsequently lead to aspiration pneumonia and even
death.16
During acute respiratory illness, patients experience an
increased ventilatory load, increased muscle weakness and ineffective secretion clearance leading to ventilatory decompensation1 as well as difﬁculties in oxygenation secondary to
secretions and mucus plugging. Therefore, the use of NIV plus
supplemental oxygen to bridge periods of respiratory illness
may be helpful. If nocturnal NIV is already in place then a transition to continuous use may be needed; short-term daytime
NIV may further help augment the effectiveness of chest physiotherapy and airway clearance. Given the progressive nature of
the disease, it is not uncommon for acute illness to lead to intubation, tracheostomy or death, especially for children with
SMA Type 1. However, in a retrospective study, Bach et sal
reported a noninvasive respiratory management approach for
respiratory failure in children with SMA Type 1.11 Using a protocol that entails targeting room air oxygen saturations greater
than 94% prior to extubation attempts, using the MI-E device
during and post extubation, and using NIV and airway clearance rather than supplemental oxygen alone when oxygen saturations dropped to less than 94% post extubation, only 1 of 11
patients required a tracheostomy following unsuccessful extubation attempts.11
NIV can also be used as a palliative care adjunct to facilitate
discharge home from hospital or to reduce the work of breathing. Birnkrant et al. published the ﬁrst case series of 4 children
with SMA Type 1 for whom NIV was initiated with a palliative
indication after the development of aspiration pneumonia.17
Although duration of survival was only 1–3 months after the
initiation of NIV, it facilitated the ability to care for these children at home.17 Two cohort studies, one prospective and one
retrospective, have since reported on the palliative application
of NIV.13,18 In these studies it is suggested that the use of NIV
in the subset of children with SMA, severe neuromuscular
weakness, and evidence of bulbar dysfunction, appeared to
transiently improve QoL for patients and their families, and
facilitate transfer home.
Although NIV is not routinely used as a prophylactic measure in other neuromuscular diseases, there is some interest in
using NIV this way in infants with SMA Type 1. It has been
suggested based on case reports of infants with SMA Type 1
who demonstrate paradoxical breathing that “high span” NIV
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(inspiratory pressure  10 cm H20 above expiratory pressure)
has the potential to reduce the pectus excavatum deformity,
improve chest wall development19 and normalize inspiratory
muscle synchrony.9
Tracheostomy and invasive ventilation
There are no randomized controlled trials evaluating the outcomes of children with SMA managed with invasive ventilation, but cohort studies demonstrate that long-term survival is
possible for children with SMA who are invasively ventilated.1,4
Invasive ventilation offers the advantage of providing a secure
airway, access for pulmonary toileting through a tracheostomy,
as well as support of ventilation, particularly if high ventilator
settings are required. However, the burden of care for families
is tremendous as the majority of patients are discharged to the
home environment. One potential complication of a tracheostomy for SMA patients is the loss of speech. It has been
described that the tracheostomy process may lead to weakness
of the bulbar muscles resulting in an inability to phonate or
make sounds, and therefore an inability to verbally communicate despite average or above average intelligence.8 Bach et al.
reported only 1 of 16 patients retained comprehensible speech
after tracheostomy insertion and similarly, only 1 maintained
the ability to spontaneously breathe.11 However, more recent
reviews suggest that speech can be retained in some children
after tracheostomy insertion.20,21 Invasive ventilation via tracheostomy may limit socialization and the attendance of school
without the appropriate resources.
Conclusion
There has been a signiﬁcant improvement in survival in recent
years for children with SMA due to the introduction of ventilatory support, airway clearance with the MI-E device, and
aggressive nutritional management. In particular, there has
been an increase in the number of patients treated with NIV.
However, despite improved survival, an appreciation for QoL
must always be tempered with the ability to prolong life, and
prognosis, based on SMA type. Special considerations should
be given when counseling families about ventilation for their
children with SMA to the type of SMA (1, 2 or 3) as well as the
age of diagnosis as these 2 factors have been shown to affect
outcomes. The advantages and disadvantages of the different
ventilation modalities must also be presented. Ultimately, the
role of the treating physician is to present all of the therapeutic
options, offer recommendations, and support the family
through the decision-making process. In clinical practice, the
parent’s authority is recognized when there is more than one
option for treatment.
Recommendations for long-term mechanical ventilation at
home in spinal muscular atrophy
1. Children with SMA whose parents would like a respiratory opinion should be referred to an experienced center
to discuss the treatment options. (Grade 1C)
2. The option of invasive and noninvasive HMV support
as well as the differences between therapeutic and

3.

4.

5.

6.

7.

palliative NIV should be presented to all parents of children with SMA. (Grade 1C)
Assessment for sleep disordered breathing (ideally with
a polysomnogram conducted as per the American Academy of Sleep Medicine standards) should be considered
for children with SMA if this is in accordance with the
child and family’s goals of care. (Grade 1C)
The decision to recommend or not recommend ventilatory support to children with Type 1 and Type 2 SMA
by the treating physician should be made on a case-bycase basis after discussion with family and other caregivers, and a careful assessment of medical beneﬁt as
well as the effect on quality of life. (Grade 1C)
Airway clearance is an important adjunct to ventilator
management in children with SMA. See Section 5 recommendations. (Grade 1C)
If children are intubated, a protocol-led extubation,
including the use of a mechanical in-exsufﬂation device
and NIV, is recommended. (Grade 1C)
When and how to augment ventilatory support during
acute illnesses should be made on a case-by-case basis
for each patient by the treating physician, as there is no
validated protocol at present. (Grade 1C)
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Section 8: Long-term mechanical ventilation at home
in muscular dystrophies
Introduction
Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy (DMD) is the most common
muscular dystrophy and is present in about 1 in 3,600 to 6,000
newborn males.1 The natural history of the disease is for lung
function to peak during the pre-adolescent period2 and then
decline due to muscle weakness by approximately 5–8% each
year in the adolescence3–8 with eventual diurnal hypercapnia
by late adolescence and death typically from respiratory failure
and death by age 20.9 However, the progression of DMD has
been favorably modiﬁed by medical treatments including systemic corticosteroids and cardiac disease speciﬁc medications.1
Congenital Muscular Dystrophies
Congenital Muscular Dystrophies (CMD) are a heterogeneous
group of diseases that present with muscle weakness and/or
hypotonia within the ﬁrst few months of life, but have variable
courses of disease progression. From a respiratory point of
view, patients may vary from needing ventilation in the neonatal period such as with A-Dystroglycan deﬁciency CMD10 to
rarely requiring any supports before the ﬁfth decade of life such
as with mild forms of Congenital Muscular Dystrophy Type
1A.11 In certain CMD such as Rigid Spine CMD, the need for
nocturnal ventilation may predate the loss of ambulation.12
Key evidence
Beneﬁt of long-term home ventilation
There is a lack of well-designed randomized control studies
evaluating the effect of long-term ventilation on survival in
children with DMD or other neuromuscular diseases. In one
study, “pre-emptive” initiation of NIV in DMD was reported to
lead to an increased mortality, however this study has been criticized for a number of methodological ﬂaws.13–15 A second
small RCT with a heterogeneous neuromuscular population
showed no difference in survival. However 9 out of 10 individuals in the control group developed daytime hypercapnia during
the 24-month follow-up period and were started on NIV.16
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Other studies have shown that the use of NIV improves gas
exchange abnormalities and normalizes blood carbon dioxide
(CO2) levels.17–19
Most evidence for the beneﬁt of nocturnal ventilation
comes from historical cohort comparative studies, from
multiple centers around the world predominately with NIV.
These demonstrated survival into the third to ﬁfth decades
of life with long-term ventilation.9,20–24 This has been maintained while maintaining QoL.19,25–27 At present, given the
large increase in survival attributable to NIV, it would not be
ethical to further evaluate NIV with new randomized control
trials. There is also emerging evidence from multiple centers
that daytime hypercapnia can be managed effectively with
nocturnal NIV in addition to daytime mouthpiece ventilation.9,28–31 However a subset of patients may still prefer or
require tracheostomies, particularly if they lack adequate neck
and/or oral control.32

Recognition of nocturnal hypoventilation
Nocturnal hypoventilation predates daytime gas exchange
abnormalities and individuals are usually asymptomatic. As
such symptom questionnaires and daytime blood gasses are
not sensitive screening tests for SDB, which includes obstructive sleep apnea, central sleep apnea, and/or nocturnal hypoventilation.33–36 Nevertheless when blood gas abnormalities are
present, they can be quite speciﬁc and indicate the need for further evaluation. In one study, the presence of elevated base
excess > 4 was 100% speciﬁc for nocturnal hypoventilation,
however in this study it only had a sensitivity of 55%.35 An
abnormal daytime pCO2 predicts nocturnal hypoventilation,
however this is a late sign that may be associated with increased
mortality.36,37
Vital Capacity remains the best-correlated test with nocturnal hypoventilation. A decrease in forced vital capacity (FVC)
correlates with an increased risk of hypoventilation and need
for ventilatory support. Several studies of adolescents and
young adults with DMD and other Neuromuscular Disorders
have demonstrated that low vital capacities of < 35–40% are
very sensitive for continuous nocturnal hypoventilation and
the need of nocturnal ventilation, however patients may be
quite symptomatic and may have daytime hypercapnia.38–40
However in at least one other study, patients with DMD already
had daytime hypercapnia with an FVC in the 40–50% predicted
range.41 In more recent studies in mixed groups of adults with
neuromuscular myopathies, an FVC < 60% was approximately
90% sensitive and speciﬁc for the onset of sleep disordered
hypopneas (REM related hypopneas) whereas an FVC < 40%
was 94% sensitive (79% speciﬁc) for continuous nocturnal
hypoventilation.35,42 In a Canadian study in children with a
heterogeneous group of children with neuromuscular disease,
Katz et al. found that FVC of less than 70% predicted had a sensitivity of 71.4% for nocturnal hypoventilation.34 Given that
dystrophinopathies are associated with cardiomyopathies and
cardiac death, earlier recognition of SDB would be important.
Maximal respiratory muscle testing including Maximal Inspiratory Pressures (MIP), Maximal Expiratory Pressures (MEP),
and Sniff Nasal Inspiratory have a weaker correlation than Vital
Capacity for nocturnal hypoventilation.34–36,40,42,43
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At present, there is no international consensus as to
when to screen for SDB in children with neuromuscular
disease. The published recommendations in the ﬁeld
include the following. The 2004 American Thoracic Society consensus statement recommends that, where available,
annual PSG testing would be ideal for surveillance. Alternatively overnight oximetry and capnography can be performed.44 The 2010 DMD Care Considerations working
group recommends nocturnal evaluation of gas exchange
when there are signs and/or symptoms of hypoventilation,
a baseline FVC < 40% predicted, and/or daytime hypercapnia with pCO2 > 45 mmHg or with a room air oxygen
saturation < 95%.45 The 2011 Canadian Thoracic Society
Adult Home Ventilation Guidelines for the same population suggest performing an evaluation for nocturnal ventilation if there are clinical signs of hypoventilation and/or
if the FEV1 or FVC is < 40% predicted.15 The 2012 British
Thoracic Society Neuromuscular Guidelines recommend
annual nocturnal assessment with PSG or oximetry when there
is a vital capacity < 60% predicted or a loss of ambulation. It
also suggests considering annual testing in infants with neuromuscular weakness, children with diaphragmatic dysfunction,
Rigid Spine Syndrome, and/or when there are symptoms of
hypoventilation.46 Polysomnograms should be conducted in
accordance with the American Academy of Sleep Medicine recommendations.47 If a polysomnogram is not available for
annual surveillance, oximetry with capnography (etCO2 and/or
tcCO2) is recommended.

Conclusions
The initiation of long-term home ventilation can lead to
prolongation of life in DMD, while maintaining QoL. The
evidence for CMD is less robust, but can be extrapolated
from the DMD literature. The primary challenge in the
pediatric age group range is knowing when and how to
recognize SDB. Decreasing vital capacity is associated with
an increased risk of nocturnal hypoventilation and the
need for ventilatory support. The evidence supports that
those with a FVC (or FEV1) < 40% predicted and/or
those who have daytime symptoms of hypoventilation
should be screened for signs of SDB, ideally with PSG, as
they are at the highest risk of hypoventilation and hypercapnia. This approach will likely miss individuals with
early and milder SDB. An FVC < 60% predicted cutoff is
likely to be a better threshold for the initiation of screening for nocturnal hypoventilation. Regardless of the vital
capacity, if the patient is symptomatic or has an abnormal
blood gas they should also undergo evaluation. As the disease progresses and daytime hypoventilation develops,
ventilatory support up to 24 hours a day can be provided
by both invasive and noninvasive methods. Noninvasive
methods may provide the advantage of decreased secretions and hospitalizations. Especially in the DMD population, candidacy for NIV plus mouthpiece ventilation to
manage diurnal hypercapnia should be evaluated prior to
tracheostomy insertion.

Recommendations for long-term mechanical ventilation at
home in muscular dystrophies
1. Assessment for sleep disordered breathing, ideally with
a polysomnogram, should be carried out not less than
annually for children with a FVC < 60% predicted
and/or who have symptoms of sleep disordered breathing. (Grade 1C)
2. Assessments for sleep disordered breathing, ideally with
a polysomnogram, should be considered annually in:
a. Infants with congenital muscular dystrophies demonstrating weakness.
b. Infants with congenital muscular dystrophies that
may develop hypoventilation < 5 years of age
(including severe forms of MDC1A and A-Dystroglycan deﬁciency congenital muscular dystrophy
CMD).
c. Children with congenital muscular dystrophies who
never attain the ability to walk or become nonambulant. (Consensus)
3. If a polysomnogram is not available for annual surveillance, oximetry and capnography (etCO2 and/or
tcCO2) are recommended. (Grade 1C)
4. Children who have shown a clinical deterioration, who
are having recurrent pulmonary exacerbations, and/or
who develop symptoms of sleep disordered breathing
may require sleep assessment more often than annually.
(Consensus)
5. Initiation of NIV should be considered when there is
evidence of diurnal hypoventilation (daytime pCO2 
45mmHg) and/or nocturnal hypoventilation (tcCO2/
etCO2 > 50mmHg for > 25% of the total sleep time)
with symptoms. (Grade 1B)
6. Initiation of NIV should be considered in patients with
evidence of SDB (hypoventilation, obstructive sleep
apnea, and/or central sleep apnea), even if asymptomatic. (Grade 1C)
7. For patients who require > 12 hours of ventilation a
day, noninvasive supports with mouth piece ventilation
should be considered as a possible alternative to tracheostomy and continuous mask NIV, factoring in individual circumstances and preferences. (Grade 1C).
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Section 9: Long-term mechanical ventilation at home
in children with kyphoscoliosis
Introduction
Kyphoscoliosis is a well-recognized cause of respiratory failure in
adults.1 In pediatrics, there is a growing body of literature on
respiratory failure secondary to early onset scoliosis as well as
scoliosis associated with other bony abnormalities of the thorax.
Surgical spinal stabilization is an integral component of the
treatment of scoliosis, and is performed to preserve respiratory
function, to prevent the future development of pulmonary hypertension, to improve quality of life by facilitating seating, and for
cosmetic reasons (to improve symmetry on standing).2,3
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Key evidence
Provision of HMV to patients with respiratory failure and
scoliosis is associated with long-term-beneﬁts
There were no studies speciﬁc to pediatric patients either
receiving HMV as a consequence of isolated scoliosis, or in
association with neuromuscular diseases.
Predictors of prolonged mechanical ventilation post-surgical
scoliosis repair
We found 11 retrospective studies reporting on 592 pediatric
patients undergoing spinal fusion surgery of which 134/558
(24%) required prolonged mechanical ventilation, deﬁned as 
36 hours.4–14 All of the studies included children with preoperative Forced Vital Capacity (FVC) percent predicted less than
30–40%. Three studies found that lower preoperative FVC %
predicted signiﬁcantly predicted the need for prolonged
mechanical ventilation.5 However, the precise values of FVC
that predict the need for postoperative ventilation varied considerably between studies, and ranged from 34 to 60; all 3 of
these studies incorporated different FVC cutoffs. Jenkins et al.
found that prolonged mechanical ventilation only occurred in
patients with FVC less than 40% predicted.21,6–7 Udink et al.
reported the mean (range) FVC % predicted in those with prolonged MV was 34% (21–25%) as compared to 62% (30–114)%
in those not needing prolonged MV.6 Finally, Yuan et al. found
that FVC < 60% predicted was the most signiﬁcant predictor
of prolonged mechanical ventilation.7 Two studies did not ﬁnd
that FVC was a signiﬁcant predictor of prolonged MV; and
similarly 2 studies found that a lower Forced Expiratory Volume in one second (FEV1) signiﬁcantly predicted the need for
prolonged mechanical ventilation.6,7,12 In those patients unable
to perform pulmonary function tests, one retrospective study
reported on the use of infant pulmonary function testing and
PSG to predict the need for mechanical ventilation post spinal
fusion, but found no signiﬁcant relationship.13 Other predictors
of prolonged mechanical ventilation reported to be signiﬁcant
by Yuan et al. included older age, male gender, and neuromuscular scoliosis etiology.7 These ﬁndings were not reproduced by
other studies. Zhang et al. found surgical approach to be the
only predictor of prolonged mechanical ventilation in their
study, while Gurajala et al. found longer vertebral fusions and
hypothermia to be associated with prolonged mechanical
ventilation.12,14
Pulmonary function post-surgical scoliosis repair
Pulmonary function following scoliosis surgery has been studied comprehensively in patients with idiopathic scoliosis but
not in patients with neuromuscular scoliosis.15–27 Following
scoliosis surgery, pulmonary function decreases dramatically in
the immediate postoperative period, although it improves during the weeks following surgery, with resolution of postoperative secretion retention and atelectasis.19 At 3 months following
surgery, many patients will have returned to baseline values,
and most will reach their preoperative baseline by 2 years postoperatively.15,17 However, many patients, particularly those
whose surgery included thoracotomy and those patients with
more advanced restrictive lung disease, may have long-term
reductions in pulmonary function.22

New surgical techniques incorporating thoracoscopic anterior approaches, may reduce morbidity and have less detrimental effects on pulmonary function.20–22 More recent studies
have demonstrated possible improvement in lung function at
2- and 3-year follow-up.26,27 Huitema et al. demonstrated a signiﬁcant improvement in FEV1 in 20 adolescents with scoliosis
at 2-year follow-up, as compared to baseline.26 Demura et al.
demonstrated similar results in a prospective cohort of 154
adolescents.27 However, the increases in absolute lung function
values that are reported are likely due to growth rather than
true improvement. There was no change in FEV1% predicted.
Reduction of morbidity post-surgical scoliosis repair
The most consistent predictor was FVC % predicted. In general, the severity of the restrictive lung disease as measured by
preoperative pulmonary function tests (PFTs) appeared to correlate with the need for prolonged mechanical ventilation in
the postoperative period.
Scoliosis patients who have not previously been on assisted
ventilation may beneﬁt from NIV following extubation.15,19
Since the introduction of postoperative NIV, failure to wean
from invasive ventilation is rare. Most patients not receiving
assisted ventilation prior to surgical correction will be able to
discontinue NIV prior to hospital discharge, although a small
proportion may need to continue on assisted ventilation at
home. Preoperative NIV and assisted cough techniques, in
addition to routine extubation to NIV post procedure will
result in a reduced incidence of failure to wean from invasive
ventilation, and may shorten hospital stay. See Section 5 on
Airway Clearance Techniques for further details.
Conclusions
In summary, the provision of HMV to patients with respiratory
failure and scoliosis is associated with long-term beneﬁts. From
the available literature, a meaningful estimate of the percentage
of patients requiring mechanical ventilation postoperatively following scoliosis repair based on FVC % predicted cannot be
determined. However, what does seem to emerge clearly from
the literature is that a mandatory preoperative tracheostomy is
no longer essential, given the improved preoperative care, surgical techniques, and outcomes. This does not preclude a frank
discussion with the patient and family regarding the risks of
spinal surgery including the possibility of prolonged ventilation
using NIV or tracheostomy in at-risk patients. It is also apparent that despite the effects of stabilization on the spine as a
result of spinal fusions, some patients may need to be maintained on assisted ventilation at home.
Recommendations for long-term mechanical ventilation at
home in children with kyphoscoliosis
1. Long-term mechanical ventilation is recommended for
all patients with kyphoscoliosis who develop chronic
respiratory failure. (GRADE 1C)
2. Preoperative pulmonary function inversely correlates
with the need for prolonged mechanical ventilation post
spinal fusion therapy. However, there is no consensus
on a deﬁnitive FVC % predicted or FEV1% predicted
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6.

7.

which predicts the need for prolonged postoperative
mechanical ventilation. (GRADE 2C)
Children should not be refused corrective scoliosis surgery on the basis of pulmonary function testing alone.
(GRADE 2C)
A tracheostomy is not mandatory for spinal fusion surgery. (GRADE 2C)
The initiation of NIV should be considered in the preoperative period. (GRADE 2C)
There should be a low threshold for the initiation of
NIV after extubation following spinal corrective surgery. (GRADE 1C)
Airway clearance techniques (breathstacking with and
without assisted cough or mechanical in-exsufﬂation)
should be provided in the postoperative period following complex spinal surgery in patients with neuromuscular scoliosis. (GRADE 1C).
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Section 10: Obesity hypoventilation in children
Introduction
Central hypoventilation is addressed in Section 11. This section
will focus speciﬁcally on hypoventilation associated with obesity, also known as obesity hypoventilation syndrome (OHS).
OHS may develop either as an isolated disorder, or as part of a
constellation of genetically related and inherited dysregulation
syndromes.
The deﬁnition of OHS in adults has been described.1 There
is no evidence to support any speciﬁc diagnostic criteria in children, other than that used in adults:
1. Obesity (BMI > 30 kg/m2) or BMI > 95 percentile for
age and gender or weight > 95 percentile for age.
2. Daytime hypercapnia (PaCO2 > 45 mmHg).
3. Absence of known neurological, cardiac or pulmonary
causes of hypoventilation.
The prevalence of OHS in pediatric patients, and the number receiving HMV, is unknown. Approximately 10–20% of

30

R. AMIN ET AL.

adults with obstructive sleep apnea (OSA) are estimated to have
OHS.2,3 Around 1–4% of children are estimated to have OSA,4
with higher rates in children with obesity. If 1% of that group
has OHS, there are still substantial numbers of children with
undiagnosed OHS. Pediatric long-term home mechanical ventilation has increased substantially, but how many are treated
for OHS is unclear.5
One study attempted to evaluate OHS in otherwise healthy
children.6 Of 326 children, 28% were obese, but there was overlap with sleep disordered breathing (SDB). The inability to
readily identify those affected with OHS is at least partially
responsible for the absence of good epidemiological data on the
prevalence of OHS among children.
Key evidence
A systematic search of the literature failed to ﬁnd any studies
that reported speciﬁcally on OHS in children.
Conclusion
The phenotype of OHS in children has not been well characterized. Clinical presentation of OHS can range from asymptomatic to presenting with acute respiratory failure. Other children
may present with indolent symptoms (snoring, apneas, headaches, etc.), daytime sleepiness or hypersomnolence, altered
cognitive function, and associated left or right heart failure.7
The diagnosis of OHS should be considered in any morbidly
obese child with symptoms of SDB, somnolence, or exercise
limitation, especially if daytime hypoxemia and hypercarbia are
present, other causes of hypoventilation being ruled out.
OHS may involve any combination of the following: morbid
obesity, altered ventilatory response, alteration of chest wall
mechanics resulting from obesity, upper airway dysfunction,
altered neuromuscular tone, with contributions from neurohormonal inﬂuences of leptin.8,9 It is unclear whether this represents a primary defect in the neurological control of breathing
or is a result of habituation of the brainstem centers to hypoxemia and hypercarbia.8,9
In adults, OHS subjects have an increased mortality,
increased hospitalization, poorer health-related QoL, decreased
vigilance, and an increased incidence of heart failure, angina,
and pulmonary hypertension.1,10 Comparable pediatric data is
not available. Whether this is also true in children has not been
conﬁrmed. QoL has been reported as improved by both caregiver and child in obese children treated with positive airway
pressure therapy, but OHS was not speciﬁcally evaluated.11
However, this study was not designed to speciﬁcally evaluate
children with OHS.
In the adult literature there is evidence to suggest that
treatment for OHS improves outcomes9 though only a small
portion obtains treatment.12 No pediatric data are available
in studies that have looked at OHS speciﬁcally for treatment
or to evaluate outcomes. When OHS has been evaluated, it
is often within a heterogeneous group of individuals. The
health care costs and beneﬁts of NIV in children with OHS
are not known.
OHS is likely an underrecognized cause of morbidity in
obese children. Evidence extrapolated from adults suggests that

positive airway pressure therapy may be effective for children
with OHS. There is uncertainty about the timing of initiation
of ventilatory support and the outcomes related to the treatment. In general, NIV can be initiated in a PSG laboratory or
in hospital. Many questions remain unanswered, both clinically
and from a research perspective, making the care for these children challenging.
Recommendations for obesity hypoventilation in children
1. All children with obesity should receive counseling
regarding nutrition, the importance of exercise, the
health care risks associated with obesity as well as the
importance of a healthy lifestyle and body weight.
(Consensus)
2. In obese children (as deﬁned above), especially those
who are symptomatic with daytime somnolence, evaluation for SDB should be undertaken with a PSG. (Grade
1C)
3. Obesity Hypoventilation Syndrome is a diagnosis of
exclusion and other causes of central hypoventilation
need to be excluded. (Grade 1C)
4. In obese children with OHS, NIV should be initiated.
(Grade 2C)
5. NIV therapy can be initiated in an outpatient sleep laboratory or on a hospital ward as an inpatient.
(Consensus)
6. Annual NIV titrations in a sleep laboratory are recommended. (Consensus)

References
1. McKim DA, Road J, Avendano M, et al. Home mechanical ventilation:
a Canadian Thoracic Society clinical practice guideline. Can Respir J
2011;18(4):197–215.
2. Mokhlesi B, Tulaimat A. Recent advances in obesity hypoventilation
syndrome. Chest 2007;132(4):1322–1336.
3. Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT.
Obesity hypoventilation syndrome: prevalence and predictors in
patients with obstructive sleep apnea. Sleep Breath 2007;11
(2):117–124.
4. Lumeng JC, Chervin RD. Epidemiology of pediatric obstructive sleep
apnea. Proc Am Thorac Soc 2008;5(2):242–252.
5. Amin R, Sayal P, Syed F, Chaves A, Moraes TJ, MacLusky I. Pediatric
long-term home mechanical ventilation: twenty years of follow-up
from one Canadian center. Pediatr Pulmonol 2013;49(8):816–824.
6. Rosen CL. Clinical features of obstructive sleep apnea hypoventilation
syndrome in otherwise healthy children. Pediatr Pulmonol 1999;27
(6):403–409.
7. Quint JK, Ward L, Davison AG. Previously undiagnosed obesity
hypoventilation syndrome. Thorax 2007;62(5):462–463.
8. Littleton SW, Mokhlesi B. The pickwickian syndrome-obesity hypoventilation syndrome. Clin Chest Med 2009;30(3):467–viii.
9. Mokhlesi B. Obesity hypoventilation syndrome: a state-of-the-art
review. Respir Care 2010;55(10):1347–1362.
10. Quint JK, Ward L, Davison AG. Previously undiagnosed obesity
hypoventilation syndrome. Thorax 2007;62(5):462–463.
11. Marcus CL, Beck SE, Traylor J, et al. Randomized, double-blind
clinical trial of two different modes of positive airway pressure
therapy on adherence and efﬁcacy in children. J Clin Sleep Med
2012;8(1):37–42.
12. Nowbar S, Burkart KM, Gonzales R, et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome.
Am J Med 2004;116(1):1–7.

CANADIAN JOURNAL OF RESPIRATORY, CRITICAL CARE, AND SLEEP MEDICINE

Section 11: Long-term mechanical ventilation at home
in children with central hypoventilation, congenital
and acquired
Introduction
Congenital Central Hypoventilation Syndrome (CCHS) is a
rare autosomal dominant disorder characterized by ventilatory
insensitivity to hypercapnia and hypoxemia during sleep and/
or wakefulness related to a mutation in PHOX2B (paired-like
homeobox 2b), a transcription factor expressed in neurons.1
CCHS may be associated with neural crest tumours, Hirschsprung’s disease,2,3 autonomic nervous system (ANS) dysfunction, cardiac arrythmias, esophageal dysmotility, pupil
abnormalities,4 breath-holding spells, as well as a lack of physiologic responsiveness to exercise and environmental stressors.5–17 The primary goal of respiratory management is
prevention of sleep-related respiratory failure. CCHS is a lifelong condition though the degree of support required may
change over time. Other causes of central hypoventilation in
infants and children are usually related to a central nervous system abnormality and may be diagnosed by brain imaging.
Key evidence
There are no randomized trials examining best ventilatory
practices. Most evidence comes in the form of case reports or
case series. However management of CCHS has been described
by experts in the ﬁeld1,18–21 and a recent American Thoracic
Society Statement on CCHS.1
Conclusions
Chronic, lifelong ventilatory support at home is the treatment
of choice for these patients because children with CCHS do not
outgrow their symptoms, current pharmacologic treatments
are ineffective, and oxygen therapy corrects the hypoxemia but
not the ventilatory derangement.16,22–25 The immediate goal of
ventilatory support is to achieve end-tidal CO2 levels between
30–50 mmHg (ideally 35–40 mmHg) and oxygen saturations
greater than 95%.18 The long-term goals of this management
are to avoid the sequelae of recurrent hypoxemia and hypercarbia, which include adverse neurologic outcomes and pulmonary hypertension with right-sided heart failure.16,26,27
Various options are available in terms of the type of support
including positive pressure ventilation via tracheostomy, noninvasive positive pressure ventilation (NIV), diaphragm pacing,
and negative pressure ventilation. Treatment should ideally be
optimized for each individual in order to achieve normal ventilation and oxygenation as assessed by standard PSG. Anticipatory
guidance and advice regarding management during intercurrent
illness, avoidance of sedating medications as well as exerciserelated precautions are also important considerations.
Recommendations for long-term mechanical ventilation at
home in children with central hypoventilation, congenital
and acquired
1. Patients with Congenital Central Hypoventilation Syndrome should receive lifelong ventilatory support in order
to avoid hypoxemia and hypercarbia. (GRADE 1C)
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2. Ventilation should be optimized to maintain as close to
normal gas exchange during wakefulness and sleep. The
ideal target levels for end-tidal/transcutaneous CO2 are
35–40 mmHg and oxygen saturations greater than 95%
during sleep. (GRADE 1C)
3. Children with Congenital Central Hypoventilation Syndrome should undergo formal titration to optimize gas
exchange (as deﬁned in criteria in no. 2 above) at least
annually by nocturnal PSG and twice a year for those
under 3 years old. (GRADE 1C)
4. Children with other Central Hypoventilation Syndromes should undergo formal titration to optimize gas
exchange (as deﬁned in criteria in no. 2 above) at least
annually by nocturnal PSG. (Grade 1C)
5. Children with Congenital Central Hypoventilation Syndrome should be discharged home with a portable
oximeter to monitor oxygen saturations. (GRADE 2C)
6. The mode (positive pressure ventilation via tracheostomy, NIV, diaphragm pacing) and degree of ventilatory support should be individualized for each patient.
(GRADE 1C).
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Section 12: Transition from pediatric to adult care
Introduction
With improvements in care and technological support, increasing numbers of children on long-term ventilation are now surviving into adulthood. This has led to the appreciation of the
impact of what is a major and predictable event in the child’s
life – transition to adult care. There is growing recognition of
the requirements from both pediatric and adult health care providers to ensure all their ongoing needs (medical, emotional,
and social) are met. An additional goal is the prevention of signiﬁcant risks associated with a transfer: patient and family anxiety, reduction in adherence to treatment or loss to follow-up
resulting deterioration in health status.
Key evidence
Although we were only able to ﬁnd a few studies speciﬁcally
addressing this issue for children on chronic ventilation, there
is a signiﬁcant literature dealing with transition of care into
adulthood for many other chronic childhood illnesses.1–6 Position statements from the Canadian Paediatric Society and
American Academy of Paediatrics, although not speciﬁcally
directed toward HMV, do have sufﬁcient commonality to
inform the care of patients on HMV.7–9 Most of the literature
in this area consists of qualitative, observational studies, and

consensus statements, with relatively little objective evidence
with respect to effectiveness of differing models of transition.10
Components necessary for a successful transition
Several reviews (that did not include children on HMV) have
recently reviewed existing data examining the effectiveness of
various transition programs.1,11 They identiﬁed 10 studies that
met their criteria for evaluation, 8 being for patients with diabetes mellitus, 1 for patients with cystic ﬁbrosis, 1 for patients following transplantation and none including patients requiring
ventilation. The methodology was very heterogeneous, with
only 4 studies comparing a standard intervention versus a control population. Despite these limitations, there were several
factors leading to a successful transition:
1. Disease speciﬁc-patient education, including self-management, preparing the patient for the transfer.
2. Creation of either speciﬁc adolescent, or joint pediatric
and adult “overlap” clinics.
3. Establishment of transition coordinators with links to
both programs, tasked with ensuring the transfer of the
patient and necessary health care information.
Available data suggest that although all these components
are required in a transition program, objective evidence would
indicate that this, in fact, occurs infrequently.12
Issues identiﬁed that need to be considered in the transfer
process include13:
1. Level of preparedness of the adolescent. The transition
from adolescence to adulthood is a gradual process, the
rate of which varies from one individual to another based
on factors such as maturity and developmental age. It has
been suggested that transition should not occur at a speciﬁc age, but rather anywhere between 17 and 20 years of
age, depending upon the level of preparedness and maturity of the patient.9
2. Level of preparedness of the system. There are signiﬁcant differences between pediatric versus adult-oriented
health care systems, particularly in terms of the type
and level of psychosocial supports, decision-making
and consent processes, and family involvement.14 Furthermore as children on home ventilation frequently
suffer from diverse, often previously fatal disorders,
adult health care providers may have limited experience
and knowledge for certain diseases.15,16 Ideally both the
pediatric and adult clinics should be prepared to discuss
issues such as sexuality and fertility, and career and
employment plans.
3. Level of preparedness of the family. Parents of children
on home ventilation are commonly a major participant
in their child’s care. Parents may therefore ﬁnd difﬁculty
in reducing their involvement to allow the adolescent the
degree of independent decision making expected by
most adult centers.14 This is further compounded if the
child has any degree of intellectual or motor limitations
impeding their ability to assume this independence.17
4. Plan of care. Explicit discussions should be undertaken to
conﬁrm the substitute decision-maker when an adolescent is unable to provide informed consent and to outline clearly for the receiving caregivers what the goals of
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care are: full treatment under all circumstances or modiﬁed goals or symptom management only.

Conclusions
Transition needs to be regarded as a gradual family-centered
process. Identiﬁcation of providers, education, and coordination of teams is essential for successful transitioning, with no
adverse sequelae on the child’s treatment or health care outcomes. Several relevant guidelines are available, including the
American Academy of Pediatrics, the Society for Adolescent
Medicine, and the Good to Go Transition program.11

Recommendations for transition from pediatric to adult
care
1. Transition planning should start early in childhood and
is an ongoing process. (Consensus)
a. The patient and their current (future) caregivers
should have a full understanding of their medical
condition and what is required for transition into
the adult health care system.
b. If feasible based on the developmental level of the
child, the patient should be involved in planning discussions in a way that is meaningful to them.
c. The adolescent needs to be involved in, and assume
the management of their condition prior to transition, to the extent that they are able.
d. Providers should encourage adolescents to complete
developmental milestones to promote attainment of
self-esteem and self-conﬁdence, to allow successful
transition, and assumption of as much independence
as their condition allows.
2. A formalized approach to transition of care is needed.
(Consensus)
a. A formal transition plan should be developed in collaboration with patient and family, by the time the
patient is 14.
b. A family physician should be identiﬁed prior to
transition. The patient and family are encouraged
to have met with the family physician before the
age of 18.
c. The formal transition program should be agreed
upon and coordinated by both the pediatric and
adult health care teams.
d. Joint transition clinics at either the pediatric or adult
health care facility are recommended.
3. Plan of care. Explicit discussions should be undertaken
to conﬁrm the substitute decision-maker when an adolescent is unable to provide informed consent. Goals of
care conversations should be had before transition and
the results of these conversations should be clearly communicated to the adult healthcare providers. (Consensus)
4. The adolescent and their caregivers need to be made
aware of how homecare supports will change as the adolescent transitions from the pediatric to adult health
care system and how this will affect, if at all, the location of care for the adolescent. (Consensus)
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Section 13: The published experience and outcomes of
family caregivers when a child is on long-term
mechanical ventilation at home
Introduction
Advances in technology and the widespread belief that children
are best cared for at home have resulted in increasing numbers
of children with stable chronic respiratory failure discharged
on home mechanical ventilation (HMV).1 In recent years, there
has been a growing appreciation of the positive and negative
consequences of the extraordinary caregiving provided by family members and other loved ones of children on HMV. This
review was undertaken to promote understanding about the
experiences and outcomes of family caregivers (FC) of children
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on HMV, upon whom we as a society and more importantly
their children rely to provide highly skilled and vigilant care in
the home, up to 24 hours per day.
Key evidence
A review of the available literature regarding the experience and
outcomes of family caregivers of children requiring HMV
retrieved a total of 1098 studies with a total of 25 independent
studies and 1 metasynthesis that met eligibility criteria. Given
the studies varied highly in terms of their methods and measurement the review was presented as a narrative.
We found 1 metasynthesis and 25 individual studies that
were informative. A metasynthesis by Lindahl and Lindblad2
provided insight into the day-to-day experience of family caregivers of children on HMV. Major themes included siblings
taking on exceptional roles and caregiving responsibilities in
the home, living in an awareness of reality and important values of life, a demanding parenthood, being in a process of
learning and meaning of space and place. Key themes described
by these papers can be summarized and described to represent
2 major outcome types and their related outcomes: physical
and mental health including QoL, caregiver burden, stress and
anxiety, and social isolation, and family function, including
normalization, caregiver competence, and parent/professional
relationships.
Health and related outcomes
Physical and mental health. FCs of children on HMV were at
a higher risk of depression, especially when supports such as
care coordination and homecare nursing levels were lacking.3–6
Increased depression was associated with poorer sleep quality
in FCs of children on HMV when compared to controls. Independent of depressive symptoms, family caregivers also
reported heightened sleep disruption.1,8 When night nursing
was not adequate, self-reported shorter sleep times were associated with greater daytime sleepiness and lower daytime functioning (p < 0.05).9 A notable limitation of these studies is the
reliance on subjective measures of sleep.10 A resourcefulness
training intervention was found to be acceptable and feasible in
a pilot study with 22 mothers of children on HMV. In this
study a 4-week, nurse-led cognitive behavioral education-based
intervention demonstrated positive impacts on mental health.11
In a study that targeted understanding of health promotion
and lifestyle among FC of children on HMV, the healthiest
scores were reported for substance use scores (eg, smoking)
and safety (eg, drinking alcohol).8 Overall health promotion
was reported to be correlated with improved functional status
of the child.8
QoL. Qualitative studies reported that parents were happy
about having their child at home.12,13 This appraisal was largely
because parents focused on the positive aspects of their lives.13–15
When validated measures of QoL were used, caregivers reported
negative aspects of emotional and physical health.16 More optimal
physical and mental health were associated with higher scores on
social support, self-esteem and psychological stability.17

Caregiver burden. Studies have described the high personal
and ﬁnancial costs incurred by parents who care for their child
on HMV.2,5,12,15,16,18 Increased responsibilities, physical
demands, and burden was also reported.5,13,15,19 One study
reported that mothers felt there were demands and expectations of ‘extraordinariness’ placed on them.4 Having reliable
family support and knowledgeable health care staff reduced the
burden of care.14 Notably the use of novel communication
strategies (telemedicine) saved time for the FCs.20
Stress and anxiety. The technical and physical aspects of caring for the child were associated with heightened anxiety.15,21
Financial expenses were also associated with increased
stress2,14,22 and increased stress was related to heightened sleep
disruption.7 Blucker3 described that coping efforts were associated with less distress and more optimal health. In contrast,
Mah21 found no difference in stress between FCs with children
on HMV compared to controls.
Social isolation. Many families expressed increased feelings of
social isolation, typically associated with not having enough
home health care and community-based help.2,13,14,17 Notably,
Miyasaka’s20 pilot study showed that having a videophone for
parents to access health care enabled the parents to have the
unexpected beneﬁt of gaining peer support.
Family functioning and related outcomes
Family function. There were mixed results reported for family
functioning. Toly23,24 described that greater depressive symptoms correlated with poorer family functioning. Having the
child at home also had positive effects on many families and
siblings as it helped them to be more understanding and compassionate21 and HMV also enabled the children to be home
with the family while receiving palliative care.25
Normalization. Most studies found that with effort, families
were able to achieve a sense of “normal” in their routine.13,15
Metasynthesis ﬁndings pointed however to the family home
feeling like a public rather than private place.2 Normalization
was correlated negatively with the mother’s depressive symptoms and positively with the child’s functional status and family
functioning (p < 0.01).24
Caregiver competence. The majority of family caregivers felt
conﬁdent and competent in caring for their child.12,14,15,19,26
Notably, the use of simulation-based education was described
in one retrospective study as an important aspect of enabling
conﬁdence and competence among FC of children on HMV.27
Parent/professional relationships. There were mixed feelings
on the part of family caregivers about the relationships they
had with professionals. Parents described that they reported
conﬂict, lack of understanding, poor communication, and
encountering inadequately prepared professionals.13,16,18,19,24
Parents expressed feeling comfortable and happy with the skills
of home caregivers7,16 while adolescents on HMV in one study
rated their care providers’ social skills lower than their parents
did.28
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Conclusions
The results of this review suggest that family caregivers of children on HMV experience a variety of outcomes impacting their
health and family functioning. Despite limitations to methods
and design, as a collective the studies signal that family caregivers (FC) of children on HMV are at risk of deleterious effects
consequent to extraordinary caregiving responsibilities. Studies
also indicate that family caregivers appreciate the opportunity
to have their child on HMV at home. Future studies are needed
to better inform the development of targeted interventions, and
inform health service delivery and related health care policy to
support and sustain the valuable contributions of FC of children on HMV.
Recommendations for the published experiences and
outcomes of family caregivers when a child is on long-term
mechanical ventilation at home
1. Family caregivers should receive an initial as well as
ongoing psychosocial assessment related to the burden
and costs (ﬁnancial, emotional) associated with caring
for a child on HMV. (Consensus)
2. Family caregivers should be assigned a ‘key worker’ or
another accountable individual to provide professional
care coordination and case management to ease the
daily workload of caregiving. (Consensus)
3. Care of the child on HMV includes routine assessment
of the health and well-being of family members including parents, siblings, and others involved in the child’s
care. If there are concerns regarding patient safety due
to issues in the family, child protective services must be
contacted. (Consensus)
4. As the use of HMV advances, family caregivers should
receive personalized services using novel technologies,
including high-ﬁdelity simulation for training purposes
that promote conﬁdence, competence, enhanced problem solving, and optimal family function. (Consensus)
5. Technology-enabled video monitoring, or other technology-enabled modalities and support should be used for
communication with the health care team to reduce
family caregiver anxiety, provide symptom support,
promote trouble-shooting of equipment challenges, and
reduce unscheduled provider visits. (Consensus).
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